![]() |
![]() |
![]() |
![]() |
1-MPS | LOWER BASOPHIL COUNT AFTER ANTI-THYMOCYTE GLOBULIN INDUCTION IS ASSOCIATED WITH A LOWER INCIDENCE OF CARDIAC ALLOGRAFT REJECTION | Bosko Skoric | ![]() |
![]() |
|||
1-MPS | TRANSPLANT RECIPIENT OUTCOMES WITH EXTENDED CRITERIA DONORS: AN ANALYSIS OF THE GUARDIAN HEART REGISTRY | Andreas Zuckermann | ![]() |
![]() |
|||
1-MPS | LEFT VENTRICULAR ASSIST DEVICES AS BRIDGE-TO-TRANSPLANTATION IN A LOW ORGAN DONOR ENVIRONMENT | Dimitris Miliopoulos | ![]() |
![]() |
|||
1-MPS | INITIAL EXPERIENCE WITH LOCAL LABORATORY RUN ASSAY TO DETECT DONOR-DERIVED CELL FREE DNA FOR NONINVASIVE DIAGNOSIS OF ACUTE MYOCARDIAL REJECTION | Stefania Manno | ![]() |
![]() |
|||
1-MPS | VALIDATION OF THE 2014 CONSENSUS PRIMARY GRAFT DYSFUNCTION DEFINITION USING THE GUARDIAN-HEART REGISTRY | Andrea Eixeres Esteve | ![]() |
![]() |
|||
1-MPS | INFLAMMATION IN BRAIN DEATH DONORS PROTECTS TO PRIMARY GRAFT DYSFUNCTION IN HEART TRANSPLANTATION | Gabriel Moreno-Gonzalez | ![]() |
![]() |
|||
1-MPS | LOCAL LABORATORY-RUN DONOR-DERIVED CELL-FREE DNA TESTING IN STABLE HEART TRANSPLANTATION: TWO-CENTRE EUROPEAN FEASIBILITY STUDY | Tímea Teszák | ![]() |
![]() |
|||
1-MPS | LIVER AFTER HEART AND COMBINED HEART LIVER TRANSPLANTATION IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: A CROATIAN EXPERIENCE | Maja Sremac | ![]() |
![]() |
|||
1-LBP | EXPLORING PERSPECTIVES ABOUT THE PSYCHOSOCIAL FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION AND TRANSPLANT OUTCOMES FOR CHILDREN | Ji Soo Kim | ![]() |
![]() |
|||
1-P | HOW COVID-19 PANDEMY INFLUENCED ON QUALIFICATION FOR KIDNEY TRANSPLANTATION IN POLAND | Jacek Zawierucha | ![]() |
![]() |
|||
1-MPS | HEART TRANSPLANTATION IN ADULTS WITH PERIPARTUM CARDIOMYOPATHY | Nadegda Koloskova | ![]() |
![]() |
|||
2-MPS | LATE OPPORTUNISTIC INFECTIONS AFTER KIDNEY TRANSPLANTATION IN THE ERA OF CONTEMPORARY IMMUNOSUPPRESSION: ROOM FOR IMPROVEMENT | Marie Matignon | ![]() |
![]() |
|||
2-P | HIGH CLASS II EPLETS MISMATCH WITH VARIABILITY- / LOW- OF TACROLIMUS LEVEL ARE ASSOCIATED WITH THE DEVELOPMENT OF DN DSA AND POOR GRAFT OUTCOMES | Dong Ryeol Lee | ![]() |
![]() |
|||
2-MPS | OUTCOME OF KIDNEY TRANSPLANTS FROM VIREMIC AND NON-VIREMIC HEPATITIS C VIRUS POSITIVE DONORS INTO NEGATIVE RECIPIENTS: RESULTS OF THE SPANISH REGISTRY | Antonio Franco | ![]() |
![]() |
|||
2-LBP | THE RISK OF MICROBIAL INFECTION IN RECIPIENTS OF DONOR LIVERS THAT UNDERWENT HYPOTHERMIC OR NORMOTHERMIC MACHINE PERFUSION | Bianca Lascaris | ![]() |
![]() |
|||
2-MPS | KIDNEY TRANSPLANTATION FROM DECEASED DONORS WITH BACTEREMIA | Maria Darema | ![]() |
![]() |
|||
2-MPS | ADVANTAGES OF MONITORING CELLULAR IMMUNE RESPONSE AGAINST CYTOMEGALOVIRUS IN RENAL TRANSPLANTATION. | Javier Arias Alcalá | ![]() |
![]() |
|||
2-MPS | THE COST-EFFECTIVENESS OF PROPHYLAXIS IN CYTOMEGALOVIRUS SEROPOSITIVE (CMV R) KIDNEY TRANSPLANT RECIPIENTS OVER THE FIRST YEAR POST-TRANSPLANTATION | Villeneuve Claire | ![]() |
![]() |
|||
2-MPS | LONG-TERM IMMUNE DYSREGULATION AFTER RITUXIMAB INDUCTION IN ABO INCOMPATIBLE LIVING-DONOR RENAL TRANSPLANTATION - IMPACT ON CHRONIC BK VIRUS INFECTION | Rolf Weimer | ![]() |
![]() |
|||
2-MPS | BKEVER STUDY: BKV CLEARANCE IN KIDNEY TRANSPLANT RECIPIENTS AFTER REPLACEMENT OF MMF BY EVEROLIMUS AND REDUCTION OF IMMUNOSUPPRESSION | Sophie Caillard | ![]() |
![]() |
|||
2-MPS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN KIDNEY TRANSPLANT RECIPIENTS : A RETROSPECTIVE MULTICENTER NATIONWIDE COHORT STUDY | adelaide Sanson | ![]() |
![]() |
|||
2-MPS | COMPASSIONATE USE PROGRAMME OF MARIBAVIR FOR ADULT PATIENTS WITH POST-TRANSPLANT REFRACTORY CMV INFECTION | Michčle Maric | ![]() |
![]() |
|||
3-MPS | THE IMPACT OF MONOCLONAL ANTIBODY AGAINST SARS-COV2 AND VACCINATION ON OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS WITH COVID-19 | Bruce Gelb | ![]() |
![]() |
|||
3-MPS | SERONEGATIVE TRANSPLANT PATIENTS REMAIN AT SIGNIFICANT RISK OF SARS-COV-2 INFECTION AND COMPLICATIONS; WE ARE NOT OUT OF THE WOODS YET | Laszlo Szabo | ![]() |
![]() |
|||
3-MPS | THE IMPACT OF EARLY THERAPIES FOR COVID IN A GROUP OF KIDNEY TRANSPLANT PATIENTS | Elena Conto | ![]() |
![]() |
|||
3-MPS | INCIDENCE AND SEVERITY OF COVID-19 IN RELATION TO ANTI-RBD IGG ANTIBODY LEVEL AFTER COVID-19 VACCINATION IN KIDNEY TRANSPLANT RECIPIENTS | Céline Imhof | ![]() |
![]() |
|||
3-MPS | REPEATED COVID-19 VACCINATION ENHANCES MEMORY T-CELL IL-21 AND MEMORY B-CELL RESPONSES IN IMMUNOCOMPROMISED KIDNEY TRANSPLANT RECIPIENTS | Reshwan Malahe | ![]() |
![]() |
|||
3-P | IMPACT OF DIFFERENT IMMUNOSUPPRESSIVE PROTOCOLS ON CLINICAL OUTCOMES IN OBESE KIDNEY TRANSPLANT RECIPIENTS: A PROPENSITY SCORE MATCHED ANALYSIS | Lina Maria Serna Higuita | ![]() |
![]() |
|||
3-MPS | REPEATED COVID-19 VACCINATION OF IMMUNOCOMPROMISED KIDNEY TRANSPLANT RECIPIENTS LEADS TO THE INDUCTION OF A FUNCTIONAL T CELL SUBSET ASSOCIATED WITH ANTIBODY PRODUCTION | Yvette den Hartog | ![]() |
![]() |
|||
3-LBP | PERFUSION PRESSURES, INTRAHEPATIC PERIVASCULAR EDEMA, AND PARADOXICAL WEIGHT LOSS DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN DONOR LIVERS | Bianca Lascaris | ![]() |
![]() |
|||
3-MPS | SAFETY AND EFFICACY OF TIXAGEVIMAB/CILGAVIMAB FOR PRE-EXPOSURE PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY | Simona Simone | ![]() |
![]() |
|||
3-MPS | SARS-COV-2 ANTIBODIES RESPONSE AFTER VACCINATIONS IN KOREAN KIDNEY TRANSPLANT RECIPIENTS | Kina Kim | ![]() |
![]() |
|||
3-MPS | TH1-DOMINANT CYTOKINE RESPONSES IN KIDNEY PATIENTS AFTER COVID-19 MRNA-1273 VACCINATION ARE ASSOCIATED WITH POOR HUMORAL RESPONSES | Yvette den Hartog | ![]() |
![]() |
|||
3-MPS | REAL-WORD EXPERIENCE OF SOTROVIMAB TO PREVENT SEVERE COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS FROM A NATIONAL STUDY | Marie Matignon | ![]() |
![]() |
|||
4-P | PANCREAS TRANSPLANT ALONE IN UREMIC (PTAU) PATIENTS | Yi-Ming Shyr | ![]() |
![]() |
|||
4-MPS | ISLET ISOLATION AFTER NORMOTHERMIC MACHINE PERFUSION OF DISCARDED HUMAN PANCREAS. A PROOF OF CONCEPT STUDY. | Catherine Parmentier | ![]() |
![]() |
|||
4-MPS | EFFECT OF RECIPIENT BODY MASS INDEX ON OUTCOME OF PANCREAS TRANSPLANTATION: A SINGLE-CENTER 20-YEAR EXPERIENCE | Samrat Ray | ![]() |
![]() |
|||
4-MPS | CONTINUOUS VS DISCONTINUOUS HUMAN ISLET PURIFICATION: A MATCHED DONOR COMPARISON. | Antoine Buemi | ![]() |
![]() |
|||
4-MPS | 40TH ANNIVERSARY OF PANCREAS TRANSPLANTATION IN SPAIN. LESSONS LEARNED AFTER MORE THAN 650 CASES IN A SINGLE CENTER | Joana Ferrer-Fŕbrega | ![]() |
![]() |
|||
4-LBP | QUALITY OF LIFE OF LIVING KIDNEY DONORS AT CHO RAY HOSPITAL:THE SHORT-FORM 36-ITEM HEALTH QUESTIONNAIRE SURVEY | CHUAN HOANG | ![]() |
![]() |
|||
4-MPS | RETRANSPLANTATION AFTER PANCREAS GRAFT FAILURE IS IT A VIABLE OPTION FOR SELECTED CANDIDATES? | Lucrezia Furian | ![]() |
![]() |
|||
4-MPS | NORMOTHERMIC EX SITU PANCREAS PERFUSION FOR THE PRESERVATION OF PORCINE PANCREAS GRAFTS | Laura Mazilescu | ![]() |
![]() |
|||
4-MPS | USING DIABETES TECHNOLOGY TO MANAGE HYPERGLYCAEMIA IN PEOPLE WITH TYPE 1 DIABETES AND FAILING PANCREAS TRANSPLANT | Thomas Johnston | ![]() |
![]() |
|||
4-MPS | EARLY RELAPAROTOMY NEED AND RISK FACTORS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Bruno José Fraga Dias | ![]() |
![]() |
|||
5-LBP | HEPATIC ARTERY COMPLICATIONS AFTER LIVER TRANSPLANTATION IN CHILDREN | Arianna Trizzino | ![]() |
![]() |
|||
5-MPS | THE MORBIDITY BURDEN AFTER LIVER TRANSPLANTATION A TREATMENT-BASED ANALYSIS | Joris COUILLEROT | ![]() |
![]() |
|||
5-MPS | FACTORS AFFECTING SIGNIFICANT DIFFERENCE BETWEEN RADIAL AND FEMORAL ARTERIAL BLOOD PRESSURE IN LIVING DONOR LIVER TRANSPLANTATION | Hyun Ji Hwang | ![]() |
![]() |
|||
5-MPS | BILIARY COMPLICATIONS FOR HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) AND UNIVERSITY OF WISCONSIN (UW) PRESERVED DECEASED DONOR LIVER GRAFTS | Gianna Fernandez | ![]() |
![]() |
|||
5-MPS | IMPACT OF DUAL HYPOTHERMIC OXYGENATED MACHINE PERFUSION (D-HOPE) ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION | Damiano Patrono | ![]() |
![]() |
|||
5-MPS | INDIVIDUALIZED HBIG WITHDRAWAL IN AN HISTORICAL COHORT OF LIVER TRANSPLANT RECIPIENTS IN ITALY. | Raffaella Vigano | ![]() |
![]() |
|||
5-MPS | EVALUATION THE SIX MONTH ABSTINENCE RULE PRIOR TO LIVER TRANSPLANT: A CLINICAL PRACTICE GUIDELINE | Joanna Dionne | ![]() |
![]() |
|||
5-MPS | LIVER TRANSPLANT RECIPIENTS WITH AUTOIMMUNE HEPATITIS IN THE SWISS TRANSPLANT COHORT STUDY HAVE A HIGHER RISK OF GRAFT LOSS AND VASCULAR COMPLICATIONS | Julien Vionnet | ![]() |
![]() |
|||
5-MPS | DO DONOR LIVER BLOOD TESTS PREDICT LIVER TRANSPLANT OUTCOMES? UK NATIONAL COHORT STUDY | Collin Wilson | ![]() |
![]() |
|||
5-P | PANCREAS TRANSPLANT WITH ENTERIC DRAINAGE: EXPERIENCE OF TAIPEI VETERANS GENERAL HOSPITAL | Yi-Ming Shyr | ![]() |
![]() |
|||
6-MPS | REGIONAL OUTCOMES OF PAEDIATRIC RENAL TRANSPLANTATION IN THE UK. A MACHINE LEARNING ANALYSIS:. | Georgios Koufopoulos | ![]() |
![]() |
|||
6-MPS | STEROID-BASED VS STEROID-FREE IMMUNOSUPPRESSION IN PAEDIATRIC KIDNEY TRANSPLANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Kavyesh Vivek | ![]() |
![]() |
|||
6-LBP | REVERSIBILITY OF DECEASED DONOR KIDNEY INJURY FOLLOWING DONATION AFTER CARDIOPULMONARY RESUSCITATION: A NATION-WIDE POPULATION-BASED COHORT STUDY | Dimitra Limnatitou | ![]() |
![]() |
|||
6-MPS | KIDNEY TRANSPLANTATION IN CHILDREN WEIGHING 10 KG OR LESS: IS IT A CHALLENGE? | Ozlem Unlugedik | ![]() |
![]() |
|||
6-MPS | CORRELATION BETWEEN CLINICAL OUTCOMES AND QUALITY OF LIFE IN PAEDIATRIC KIDNEY TRANSPLANT RECIPIENTS. | Jelena Stojanovic | ![]() |
![]() |
|||
6-MPS | BASILIXIMAB VS ANTI-THYMOCYTE/ANTI-LYMPHOCYTE GLOBULINS IN PEDIATRIC KIDNEY TRANSPLANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS | Mikhail Nozdrin | ![]() |
![]() |
|||
6-MPS | EFFECT OF DONOR TYPE ON GRAFT AND PATIENT SURVIVAL IN PAEDIATRIC RECIPIENTS OF KIDNEY AND LIVER TRANSPLANTATION. | Mikhail Nozdrin | ![]() |
![]() |
|||
6-MPS | SYSTEMATIC DIGITAL ASSESSMENT OF PATIENT-REPORTED OUTCOMES IN CLINICAL FOLLOW-UP OF PEDIATRIC KIDNEY TRANSPLANTATION PATIENTS: A PILOT STUDY. | Fabian Eibensteiner | ![]() |
![]() |
|||
6-MPS | DONOR-DERIVED CELL-FREE DNA (DD-CFDNA) AS A NON-INVASIVE BIOMARKER OF KIDNEY ALLOGRAFT REJECTION IN PEDIATRIC KIDNEY TRANSPLANTATION. | Julien Hogan | ![]() |
![]() |
|||
6-MPS | THE EFFECT OF HLA MISMATCHES ON POST-TRANSPLANT OUTCOMES IN PAEDIATRIC RENAL TRANSPLANTATION | Vivek Kavyesh | ![]() |
![]() |
|||
6-MPS | RENAL ALLOGRAFT SURVIVAL FOR (RE)TRANSPLANTED CHILDREN IN ADULTHOOD; AN ERA REGISTRY STUDY FROM 1978 TO 2019. | Evgenia Preka | ![]() |
![]() |
|||
7-LBP | ISCHEMIC PRECONDITIONING AMELIORATES MOUSE RENAL ISCHEMIA-REPERFUSION INJURY THROUGH ACTIVATING THE NRF2/HO-1 PATHWAY ENHANCED AUTOPHAGY | Eun Sil Koh | ![]() |
![]() |
|||
7-P | REASONS FOR DEATH WITH A FUNCTIONING KIDNEY GRAFT AND REASONS FOR OVERALL GRAFT FAILURE | Manuel Mayrdorfer | ![]() |
![]() |
|||
8-P | PREDICTION MODELS FOR IDEAL GRAFT FUNCTION AFTER LIVING DONOR KIDNEY TRANSPLANTATION ARE USEFUL TO PREDICT GRAFT SURVIVAL | Takahisa Hiramitsu | ![]() |
![]() |
|||
9-P | METABOLOMICS APPROACH AND GRAFT FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Dedinská | ![]() |
![]() |
|||
9-LBP | EXPERIENCE AND BURDEN OF POST-TRANSPLANT CYTOMEGALOVIRUS INFECTION AND TREATMENT FROM THE PATIENTS PERSPECTIVE | Kimberly Davis | ![]() |
![]() |
|||
10-LBP | CAN CT ANGIOGRAPHY REPLACE RENAL SCINTIGRAPHY FOR PREDICTION OF SPLIT RENAL FUNCTION IN PREOPERATIVE LIVING KIDNEY DONOR ASSESSMENT? | David Martin | ![]() |
![]() |
|||
11-LBP | OPTIMIZATION OF HLA MATCHING IN KIDNEY ALLOCATIONS, WITH MINIMAL EFFECT ON QUEUE | Sapir Israeli | ![]() |
![]() |
|||
11-P | Neonatal Kidney Donation for Kidney Shortage: Is this the time? | Dai Nghiem | ![]() |
![]() |
|||
12-P | VERY LOW DOSE ANTI-THYMOCYTE GLOBULINS VERSUS BASILIXIMAB IN NON-IMMUNIZED KIDNEY TRANSPLANT RECIPIENTS | Christophe Masset | ![]() |
![]() |
|||
13-P | OPERATING THEATRE NURSESMAIN CONCERNS DURING THE OPERATIVE PROCESS OF ORGAN DONATION- A GROUNDED THEORY | Linda Andersson | ![]() |
![]() |
|||
14-LBP | IMPROVED KIDNEY PRESERVATION BY OMNISOL COMPARED TO RED BLOOD CELL BASED PERFUSATE FOR 6 HOUR NORMOTHERMIC MACHINE PERFUSION | Benedict Doorschodt | ![]() |
![]() |
|||
14-P | LONG-TERM RESULTS OF AB-INITIO INTRODUCTION OF EVEROLIMUS AFTER LIVER TRANSPLANTATION | Domiziana Pedini | ![]() |
![]() |
|||
15-P | RESPONSE TO COVID-19 VACCINATION AND CONTIXAGEVIMAB-CILGAVIMAB PROPHYLAXIS IN PATIENTS UNDERGOING LIVER AND KIDNEY TRANSPLANTATION: PRELIMINARY STUDY | Domiziana Pedini | ![]() |
![]() |
|||
15-LBP | SINGLE-CELL RNA-SEQ REVEALS THE HETEROGENEITY OF MICROENVIRONMENT BETWEEN BKPYVN AND TCMR | Gang Huang | ![]() |
![]() |
|||
16-LBP | OUTCOMES FOR DECEASED DONOR KIDNEY TRANSPLANT FOLLOWING DONOR CARDIAC ARREST: A NATION-WIDE POPULATION-BASED COHORT STUDY | Dimitra Limnatitou | ![]() |
![]() |
|||
16-P | PRE-TRANSPLANT MYCOPHENOLATE MOFETIL MAY BE ASSOCIATED WITH REDUCED INTRAHEPATIC CHOLANGIOPATHY IN ABO-INCOMPATIBLE LIVER TRANSPLANTATION | Jinsoo Rhu | ![]() |
![]() |
|||
17-LBP | SURVIVAL BENEFIT OF KIDNEY TRANSPLANTATION IN PATIENTS WITH END-STAGE KIDNEY DISEASE AND PRIOR ACUTE MYOCARDIAL INFARCTION | Jae Won Yang | ![]() |
![]() |
|||
17-P | HEPATIC ARTERIAL REVASCULARIZATION IN THE FIRST 72 HOURS FOLLOWING LIVING-DONOR LIVER TRANSPLANTATION: SURGICAL OR ENDOVASCULAR?- A PROPOSED ALGORITHM | Ayman M. Abdelhady Osman | ![]() |
![]() |
|||
18-P | USE OF ECULIZUMAB IN A CASE OF HISTOLOGICALLY PROVEN RECURRENCE OF COMPLEMENT FACTOR H - RELATED 5 PROTEIN NEPHROPATHY TO A KIDNEY ALLOGRAFT | Isavella Savva | ![]() |
![]() |
|||
19-P | PEDIATRIC ORGAN DONATION: SIXTEEN-YEAR EXPERIENCE OF A PEDIATRIC INTENSIVE CARE UNIT / INTENSIVE CARE UNIT IN A LEVEL 3 HOSPITAL FROM 2006 TO 2021 | Sara Rodrigues | ![]() |
![]() |
|||
20-LBP | FIVE-YEAR KIDNEY FUNCTION AND OUTCOMES IN ASIAN KIDNEY TRANSPLANT RECIPIENTS CONVERTING FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS | Jaymini Patel | ![]() |
![]() |
|||
21-LBP | NO NUMBER TOO HIGH FOR KIDNEY TRANSPLANT RECIPIENTS - UNVEILING THE IMPACT OF A SIXTH mRNA VACCINE DOSE | Markus Hovd | ![]() |
![]() |
|||
21-P | THE IMPACT OF DONOR AGE =50 ON PURE LAPAROSCOPIC DONOR RIGHT HEPATECTOMY | Eui Soo Han | ![]() |
![]() |
|||
22-P | ISOLATED GLOMERULITIS IS STRONGLY ASSOCIATED WITH THE ABSENCE OF ANTIBODY-MEDIATED REJECTION BY MOLECULAR DIAGNOSTICS | Thomas Schachtner | ![]() |
![]() |
|||
22-LBP | EXPLORING THE MOLECULAR PATHWAYS OF INTRACRANIAL ANEURYSM FORMATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE USING PROTEOMIC ANALYSIS | Jin-Myung Kim | ![]() |
![]() |
|||
23-LBP | ISCHEMIA-FREE LIVER IMPLANTATION VERSUS NORMOTHERMIC MACHINE PERFUSION: EVALUATION OF FEASIBILITY AND SECURITY | Zhitao Chen | ![]() |
![]() |
|||
23-P | TAB-CEL FOR EBV PTLD AFTER FAILURE OF RITUXIMAB CHEMOTHERAPY FOLLOWING SOLID ORGAN OR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT ALLELE | Farsad Eskandary | ![]() |
![]() |
|||
24-P | SUCCESSFUL INTERNATIONAL ADOPTION OF A COMPREHENSIVE, INTEROPERABLE, AND SECURE DIGITAL ORGAN OFFERING MANAGEMENT PLATFORM | Jonathan Baldanza | ![]() |
![]() |
|||
25-P | THE QUALITY OF LIFE AND QUALITY OF SLEEP SCORE BETWEEN DIALYSIS AND RENAL TRANSPLANTATION | Sanaz Dehghani | ![]() |
![]() |
|||
26-P | PREDICTORS OF NON ADHERENCE TO IMMUNOSUPPRESSION IN RENAL TRANSPLANT PATIENTS AT A UNIVERSITY TEACHING HOSPITAL | Georgios Koufopoulos | ![]() |
![]() |
|||
26-LBP | ADVANCED MULTIPLEX FLUORESCENCE MICROSCOPY OF AN EXPERIMENTAL PORCINE LUNG TRANSPLANT MODEL | Nicholas Bechet | ![]() |
![]() |
|||
27-P | SUBJECTIVE FRAILTY ASSESSMENT COMPARED TO VALIDATED FRAILTY ASSESSMENT IN DIALYSIS ACCESS/TRANSPLANT SURGERY WORKUP HAS POOR ESTIMATION OF AGREEMENT | Georgios Koufopoulos | ![]() |
![]() |
|||
28-P | CHORIOCARCINOMA TRANSMITTED WITH THE TRANSPLANT: CASE STUDY | Sanaz Dehghani | ![]() |
![]() |
|||
28-LBP | EFFECTS OF HYPOTHERMIC MACHINE PERFUSION ON THE ENDOTHELIUM IN HUMAN KIDNEYS | Leonie Venema | ![]() |
![]() |
|||
29-P | PREDICTORS AND ADVERSE OUTCOMES OF ACUTE KIDNEY INJURY IN HOSPITALIZED RENAL TRANSPLANT RECIPIENTS | Tammy Hod | ![]() |
![]() |
|||
30-P | EVALUATION OF THE CLINICAL EXPRESSION OF IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS | Tammy Hod | ![]() |
![]() |
|||
30-LBP | HEPATITIS B SURFACE ANTIGEN POSITIVE DONORS FOR LIVER RECIPIENTS WITH HEPATOCELLULAR CARCINOMA: A SINGLE CENTRE EXPERIENCE | Bianca Magro | ![]() |
![]() |
|||
31-P | NORMOTHERMIC MACHINE PERFUSION INDUCED REMARKABLE BIOLOGICAL CHANGESOF MARGINAL DONOR KIDNEYS AS DEMONSTRATED BY PROTEOMICS. | Gianluigi Zaza | ![]() |
![]() |
|||
31-LBP | ACTIVE PARTICIPATION DURING THE EDUCATIONAL PROCESS OF DONATION AFTER CIRCULATORY DEATH AT EXTRA CORPOREAL MEMBRANE OXYGENATION INTENSIVE CARE UNITS. | Emilie Gripewall | ![]() |
![]() |
|||
32-LBP | CHANGES IN ENDOGENOUS PEPTIDES IN DCD KIDNEY BIOPSIES ASSOCIATE WITH PROLONGED WARM ISCHAEMIA | Rebecca Vaughan | ![]() |
![]() |
|||
32-P | ESOT-TLJ 3.0 CONSENSUS ON HISTOPATHOLOGICAL ANALYSIS OF PRE-IMPLANTATION DONOR KIDNEY BIOPSY: REDEFINING THE ROLE IN THE PROCESS OF GRAFT ASSESSMENT. | Gianluigi Zaza | ![]() |
![]() |
|||
33-P | MULTI-CENTRIC ANALYTICAL PERFORMANCE VALIDATION OF AN IVD ASSAY TO QUANTIFY DONOR-DERIVED CELL-FREE DNA FOR SOLID ORGAN TRANSPLANT SURVEILLANCE | Thierry Viard | ![]() |
![]() |
|||
34-LBP | 440 CONSECUTIVE HAND-ASSISTED-RETROPERITONEOSCOPIC-DONOR-NEPHRECTOMIES(HARP). A COMPREHENSIVE ANALYSIS OF THE INTRAOPERATIVE CHALLENGES. | Tristan Wagner | ![]() |
![]() |
|||
36-LBP | INCREASED PERCENTAGES OF CD8DR T-CELLS IN PATIENTS WITH DIFFICULT TO CONTROL CMV INFECTION IN SOLID ORGAN RECIPIENTS: A NEW BIOMARKER? | Javier Carbone | ![]() |
![]() |
|||
36-P | URINARY RETINOL-BINDING PROTEIN 4 IS ASSOCIATED WITH RENAL FUNCTION AND RAPID RENAL FUNCTION DECLINE IN KIDNEY TRANSPLANT RECIPIENTS | Samuel Lee | ![]() |
![]() |
|||
37-P | DEVELOPING A STANDARDIZED EDUCATION PROGRAM ON DECEASED ORGAN AND TISSUE DONATION FOR PRE-MEDICAL AND MEDIAL STUDENTS IN KOREA | Samuel Lee | ![]() |
![]() |
|||
38-LBP | JOINT ALLOTRANSPLANTATION: A SYSTEMATIC LITERATURE REVIEW AND EXPERIMENTAL EXAMINATION OF IMMUNE REJECTION OF CARTILAGE | lei zhang | ![]() |
![]() |
|||
38-P | TOCILIZUMAB FOR CHRONIC ANTIBODY-MEDIATED REJECTION- 5 YEARS OF EXPERIENCE | Bojana imunov | ![]() |
![]() |
|||
39-P | MAGNETIC RESONANCE IMAGING OF RENAL OXYGEN METABOLISM BY MEANS OF 17O ADMINISTRATION DURING EX VIVO ORGAN PERFUSION | Carolina Campos Pamplona | ![]() |
![]() |
|||
39-LBP | ACCESS TO AND RESULTS OF TRANSPLANTS IN CATALONIA; REVIEW FROM THE STANDPOINT OF GENDER. | Jaume Tort | ![]() |
![]() |
|||
40-P | VOXE: TRANSFORMING CARE IN SOLID ORGAN TRANSPLANT THROUGH THE INTEGRATION OF A DIGITAL PATIENT-REPORTED OUTCOME PLATFORM IN CLINICAL PRACTICE | Samantha Anthony | ![]() |
![]() |
|||
40-LBP | GRAFT FAILURE AND DEATH AMONG OLDER PRIMARY DECEASED DONOR KIDNEY RECIPIENTS IN THE UNITED STATES | Samy Riad | ![]() |
![]() |
|||
41-P | CREATION OF AN ORGAN TRANSPLANT CAREGIVER EDUCATIONAL RESOURCE & LESSONS LEARNED | Heather Bruschwein | ![]() |
![]() |
|||
42-LBP | ISCHEMIA-FREE LIVER TRANSPLANTATION AS A NOVEL APPROACH TO OPTIMIZE TRANSPLANT OUTCOME IN THE ACUTE-ON-CHRONIC LIVER FAILURE SCENARIO | Jun Kang | ![]() |
![]() |
|||
43-P | THE OUTCOMES OF ADJUSTED IMMUNOSUPPRESSIVE PROTOCOLS DURING DIFFERENT PHASES OF COVID-19 PANDEMIC IN KIDNEY TRANSPLANT RECIPIENTS | aglar Ruhi | ![]() |
![]() |
|||
43-LBP | SUCCESSFUL REPLANTATION OF PORCINE FORELIMBS 33 HOURS AFTER AMPUTATION USING 24-HOUR EX VIVO PERFUSION | lei zhang | ![]() |
![]() |
|||
44-LBP | EX VIVO CHARACTERIZATION OF KIDNEY TRANSPLANT TUBULAR EPITHELIAL CELL CO-STIMULATORY AND -INHIBITORY MOLECULE EXPRESSION DURING INFLAMMATION | Constantin Thieme | ![]() |
![]() |
|||
45-LBP | SURFACE MOLECULE EXPRESSION OF KIDNEY TUBULAR EPITHELIAL CELL DERIVED EXTRACELLULAR VESICLES A NEW PERSPECTIVE ON THE MODULATION OF ALLOIMMUNITY? | Luka Queitsch | ![]() |
![]() |
|||
46-LBP | UNSUPERVISED ANALYSIS OF KIDNEY BIOPSY TRANSCRIPTOMES FROM DONORS AFTER BRAINSTEM OR CARDIAC DEATH | Rachel Thomas | ![]() |
![]() |
|||
46-P | PREDICTION OF HERPES VIRUS INFECTIONS AFTER SOLID ORGAN TRANSPLANTATION: A PROSPECTIVE STUDY OF IMMUNE FUNCTION | Dina Leth Mller | ![]() |
![]() |
|||
47-P | PREGNANCY OUTCOMES IN FEMALE ABDOMINAL ORGAN TRANSPLANT RECIPIENTS | Lisa Coscia | ![]() |
![]() |
|||
48-P | EVEROLIMUS POSSIBLY SUPPRESS ANTI-HLA CLASS II PRODUCTION AFTER LIVING DONOR RENAL TRANSPLANTATION | Shunji Narumi | ![]() |
![]() |
|||
49-P | THE DIFFERENCE BETWEEN ECHOCARDIOGRAPHIC FINDINGS BASED ON THE CAUSE OF BRAIN DEATH: A SINGLE-CENTER STUDY IN SINA ORGAN PROCUREMENT UNIT | Azadeh Sadatnaseri | ![]() |
![]() |
|||
49-LBP | IMPACT OF PROLONGED NORMOTHERMIC MACHINE PERFUSION ON THE BIOENERGETIC FUNCTION IN PORCINE DBD KIDNEYS | Marlene Pühringer-Sturmayr | ![]() |
![]() |
|||
51-LBP | ANEMIA AFTER KIDNEY TRANSPLANTATION - HOW CAN WE MANAGE? | Ivana Dedinská | ![]() |
![]() |
|||
51-P | A LOW ABUNDANCE OF HLA IN URINARY EXTRACELLULAR VESICLES HINDERS THE IDENTIFICATION OF DONOR-SPECIFIC VESICLES IN URINE AFTER KIDNEY TRANSPLANTATION | Karin Boer | ![]() |
![]() |
|||
52-LBP | THE DETRIMENTAL EFFECTS OF A BK POLYOMAVIRUS INFECTION IN KIDNEY TRANSPLANT PATIENTS | Wouter Moest | ![]() |
![]() |
|||
53-LBP | ASSOCIATION OF HEMOGLOBIN LEVELS WITH RENAL FUNCTION DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE KIDNEYS: A RETROSPECTIVE COHORT STUDY | L. Annick van Furth | ![]() |
![]() |
|||
53-P | ANALYSIS OF TREATMENT PREFERENCES, NEEDS, IMMUNOSUPPRESSANT ADHERENCE, AND MENTAL HEALTH DISORDERS IN KIDNEY TRANSPLANT PATIENTS | Carlos Jimenez | ![]() |
![]() |
|||
54-P | CLINICAL EFFECTS OF VALACYCLOVIR-BASED CYTOMEGALOVIRUS PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS | Jin Sug Kim | ![]() |
![]() |
|||
55-P | SELECTION OF SAFE DONORS FOR THE LIVING DONOR LIVER TRANSPLANTATION USING EXTENDED RIGHT LOBE GRAFT | Sung Yeon Hong | ![]() |
![]() |
|||
55-LBP | GROUND BREAKING DECISIONAL ROLE OF TRANSIT TIME DURING A LIVING DONOR TRANSPLANTATION EVALUATED BY A FAST AND FRUGAL TREE | Gianluca Rompianesi | ![]() |
![]() |
|||
56-P | SYSTEMIC IMMUNE-INFLAMMATORY MARKER OF HIGH MELD PATIENTS IS ASSOCIATED WITH EARLY MORTALITY AFTER LIVER TRANSPLANTATION | Sung Yeon Hong | ![]() |
![]() |
|||
56-LBP | 35 YEARS OF PAEDIATRIC HEART TRANSPLANTATION: OUTCOMES AT A VERY LONG TERM FOLLOW-UP | Chiara Tessari | ![]() |
![]() |
|||
57-P | MALIGNANCY AFTER KIDNEY TRANSPLANT - 50 YEARS EXPERIENCE | Shunji Narumi | ![]() |
![]() |
|||
58-LBP | HEART TRANSPLANTATION (HTX) IN ELDERLY PATIENTS: CROSS-SECTIONAL SINGLE CENTER OBSERVATIONAL STUDY | Agnieszka Kuczaj | ![]() |
![]() |
|||
58-P | A LOW SURGICAL APGAR IS A STRONG DETERMINANT OF THE RISK OF DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION | Florent Von Tokarski | ![]() |
![]() |
|||
59-P | PRETRANSPLANT HBA1C AS AN EASY TOOL TO IDENTIFY PATIENTS AT HIGH RISK OF DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION | yassine Laghrib | ![]() |
![]() |
|||
59-LBP | PROLONGED EX VIVO KIDNEY PRESERVATION USING SUBNORMOTHERMIC ACELLULAR MACHINE PERFUSION | Sara Akalay | ![]() |
![]() |
|||
60-P | COMPARING OUTCOMES IN EXTENDED VERSUS STANDARD CRITERIA LIVING DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTRE ANALYSIS | Nikolaos-Andreas Anastasopoulos | ![]() |
![]() |
|||
60-LBP | PRELIMINARY RESULTS OF CYTOKINE PROFILING AND ADSORPTION DURING SUBNORMOTHERMIC MACHINE PERFUSION OF ECD LIVER GRAFTS | Sabrina Stimmeder | ![]() |
![]() |
|||
61-P | PROSPECTIVE ASSESSMENT OF THE NEED FOR AND ADDED VALUE OF MOLECULAR DIAGNOSTICS OF KIDNEY ALLOGRAFT BIOPSIES AN EVALUATION IN CLINICAL PRACTICE | Thomas Schachtner | ![]() |
![]() |
|||
62-P | EFFECTS OF A QUADRUPLE IMMUNOSUPPRESSANT REGIMEN INCLUDING EARLY ADD-ON EVEROLIMUS AFTER KIDNEY TRANSPLANTATION | Hitoshi Iwamoto | ![]() |
![]() |
|||
63-LBP | DONATION AFTER CIRCULATORY DEATH INCREASES OVERALL ORGAN DONATION AND TRANSPLANTATION IN SWEDEN, BUT NOT WITHOUT NEW CHALLENGES. | Helena Almén | ![]() |
![]() |
|||
63-P | THE IRANIAN EXPERIENCE OF PEDIATRIC ORGAN DONATION | Sanaz Dehghani | ![]() |
![]() |
|||
64-P | PATIENTS PERSPECTIVE AND UTILITY OF SELF-NARRATIVE BIOGRAPHIES IN THE KIDNEY TRANSPLANTATION PATH | Marika Morabito | ![]() |
![]() |
|||
64-LBP | HEART TRANSPLANTATION FROM ANTI-HBCORE POSITIVE DONORS: A SINGLE-CENTER OBSERVATIONAL STUDY | Agnieszka Kuczaj | ![]() |
![]() |
|||
65-LBP | THE IMPACT OF DECEASED DONOR ORGAN PROCUREMENT WORKSHOP ON SURGICAL TRANSPLANT FELLOWS CONFIDENCE AND COMPETENCE | Shilpa Balaji | ![]() |
![]() |
|||
65-P | VITALLINKS SCHOOL EDUCATION PROGRAM TO NURTURE THE VALUE OF SHARING AND DECEASED ORGAN DONATION FOR TEENAGERS | Jieun Oh | ![]() |
![]() |
|||
66-LBP | DISTINCT CYTOKINE SIGNATURES ACCORDING TO MODEL FOR END-STAGE LIVER DISEASE SCORES AFTER LIVING DONOR LIVER TRANSPLANTATION | Ami Woo | ![]() |
![]() |
|||
67-LBP | SURGICAL TREATMENT OF THE PAPILLARY RENAL CELL CARCINOMA IN THE TRANSPLANTED KIDNEY. CASE REPORT | Stefan Hulik | ![]() |
![]() |
|||
68-P | TRANSMISIÓN DE VIRUS DE LA HEPATITIS C DE DONANTE VIRÉMICO A RECEPTOR SERONEGATIVO A TRAVÉS DEL INJERTO TEJIDO. UN ESTUDIO PROSPECTIVO | Antonio Franco | ![]() |
![]() |
|||
69-LBP | DIGITAL DONOR EVALUATION TOOL: A NEW TECHNOLOGY IMPROVES DONOR ENROLLMENT ON INTENSIVE CARE UNIT | Chiara Selina Imbimbo | ![]() |
![]() |
|||
70-LBP | RENAL INSUFFICIENCY CAUSES RAPID GROWTH OF PEDIATRIC KIDNEY GRAFT IN A PEDIATRIC-TO-ADULT KIDNEY TRANSPLANTATION RAT MODEL | Tianhui Pan | ![]() |
![]() |
|||
70-P | 17?-ESTRADIOL AND METHYLPREDNISOLONE ASSOCIATED EFFECTS ON RENAL INFLAMMATION INDUCED BY BRAIN DEATH IN FEMALE RATS | Marina Vidal dos Santos | ![]() |
![]() |
|||
71-LBP | ATTACHMENT AND PARENTAL BOND: IMPACT ON PSYCHOPATHOLOGY, MENTAL HEALTH AND QUALITY OF LIFE OF KIDNEY TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL STUDY | Maria Luisa Pistorio | ![]() |
![]() |
|||
71-P | FIRST ROUTINE CLINICAL APPLICATION OF MOLECULAR MICROSCOPE (MMDX) IN EUROPE | Ondrej Viklicky | ![]() |
![]() |
|||
72-P | PERFORMANCE OF A NOVEL NGS ASSAY SUITABLE FOR MONITORING DD-CFDNA FOLLOWING KIDNEY TRANSPLANTATION | Sofia Carlén | ![]() |
![]() |
|||
73-P | A MULTI-CENTRE STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF EXTENDED-RELEASE TACROLIMUS (LCPT) IN DE NOVO LIVER TRANSPLANT PATIENTS | Thomas Soliman | ![]() |
![]() |
|||
74-P | FROM PEN TO CLOUD INTRODUCTION OF A DIGITAL DOCUMENTATION PLATFORM FOR ORGAN DONATION COORDINATORS | Marcus Nauwerk | ![]() |
![]() |
|||
79-P | HYPERTENSION AFTER LIVING DONOR KIDNEY DONATION IN THE ERA OF EXTENDED DONOR ELIGIBILITY CRITERIA | Rostand Emmanuel Nguefouet Momo | ![]() |
![]() |
|||
80-P | PLASMA CELL-FREE DEOXYRIBONUCLEIC ACID AND SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS | Alison Graver | ![]() |
![]() |
|||
81-P | REVISED USUAL INTERSTITIAL PNEUMONIA DIAGNOSES IN EXPLANT LUNGS AFTER THE CURRENT INTERNATIONAL GUIDELINES: A 17-YEAR BICENTRIC EXPERIENCE | Federica Pezzuto | ![]() |
![]() |
|||
82-P | CLINICAL OUTCOMES AND QUALITY OF LIFE IN CHILDREN WITH METHYLMALONIC ACIDAEMIA AND END-STAGE KIDNEY DISEASE; A PROMISING FUTURE | Charalampos Kapogiannis | ![]() |
![]() |
|||
85-P | FUROSEMIDE ATTENUATES TUBULOINTERSTITIAL INJURY AND ALLOWS FUNCTIONAL TESTING OF PORCINE KIDNEYS DURING NORMOTHERMIC MACHINE PERFUSION | Baran Ogurlu | ![]() |
![]() |
|||
86-P | REPROGRAMMING MITOCHONDRIAL METABOLISM TO REDUCE ORGAN TRANSPLANT ISCHEMIA REPERFUSION INJURY | Margaret Huang | ![]() |
![]() |
|||
88-P | KINETICS OF POST-TRANSPLANTATION DIABETES MELLITUS IN A LARGE COHORT OF KIDNEY TRANSPLANT PATIENTS | Anne Elisabeth Heng | ![]() |
![]() |
|||
89-P | JEJUNAL OR ILEAL EXOCRINE DRAINAGE IN PANCREAS TRANSPLANTATION? GASTROINTESTINAL IMPACT | Jaimee Tan | ![]() |
![]() |
|||
90-P | LONG-TERM RESULTS OF HEART TRANSPLANTATION IN RECIPIENTS WITH PRIMARY CARDIAC SARCOMA | Anna Goncharova | ![]() |
![]() |
|||
91-P | HEALTH-RELATED QUALITY OF LIFE IN OLDER RECIPIENTS: THE BRIGHT SIGHT OF LIFE FIVE YEARS AFTER KIDNEY TRANSPLANTATION | Vasiliki Tsarpali | ![]() |
![]() |
|||
92-P | EFFECT OF BASILIXIMAB INDUCTION IN PEDIATRIC KIDNEY TRANSPLANTATION. A SYSTEMATIC REVIEW AND META-ANALYSIS. | Kavyesh Vivek | ![]() |
![]() |
|||
93-P | OPTIMAL TACROLIMUS LEVELS FOR PREVENTING MALIGNANCY AS WELL AS GRAFT FAILURE IN KIDNEY TRANSPLANT PATIENTS | Jaeseok Yang | ![]() |
![]() |
|||
94-P | CHALLENGES EXPERIENCED BY ADULT LIVER DONORS AFTER LIVING DONOR LIVER TRANSPLANTATION: AN INTEGRATIVE REVIEW | Seongmi Choi | ![]() |
![]() |
|||
95-P | LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: IS THERE A CURATIVE TREATMENT FOR DISSEMINATED RECURRENCE? | Maria Arteaga Ledesma | ![]() |
![]() |
|||
96-P | Aspects of Self-Management after Solid Organ Transplantation | Stefan Jobst | ![]() |
![]() |
|||
97-P | HYPOTHERMIC OXYGENATED MACHINE PERFUSION IN EXTENDED CRITERIA DONORS, A SPANISH EXPERIENCE | Alberto Pueyo Rabanal | ![]() |
![]() |
|||
98-P | ORGAN DONATION IN PATIENTS ON VENOARTERIAL ECMO SUPPORT - SINGLE CENTER EXPERIENCE | Lukas Kielberger | ![]() |
![]() |
|||
99-P | CLINICAL PERFORMANCE OF THE IPREDICTLIVING TOOL FOR THE PREDICTION OF POST-TRANSPLANT RECIPIENT AND LIVING DONOR OUTCOMES IN A EUROPEAN COHORT | Jorge Malheiro | ![]() |
![]() |
|||
100-P | WALKING IS FUN BUT WALKING TOGETHER IS EVEN MORE FUN: AN EVALUATION OF THE WALK&TALK PROGRAM IN THE NETHERLANDS. | Coby Annema | ![]() |
![]() |
|||
101-P | BROADENING CRITERIA FOR DONOR LIVERS: SUCCESSFUL LIVER TRANSPLANTATION OF TWO DONOR LIVERS WITH PORTAL VENOUS GAS | Rama Mikhail | ![]() |
![]() |
|||
102-P | IMPACT OF HEMOADSORPTION ON PHARMACOKINETICS OF IMMUNOSUPPRESSIVE DRUGS IN A SHEEP MODEL | Teresa Klaus | ![]() |
![]() |
|||
103-P | YOU CAN LEARN FROM EACH OTHER AND GROW: EXPERIENCES OF ADOLESCENT THORACIC TRANSPLANT RECIPIENTS PARTICIPATING IN THE IPEER2PEER MENTORSHIP PROGRAM | Samantha Anthony | ![]() |
![]() |
|||
104-P | IMPROVEMENT GAPS TO DEAL WITH THE SHORTAGE OF LUNGS FOR TRANSPLANTATION FROM A MIDDLE INCOME COUNTRYS PERSPECTIVE | Brian Alvarez | ![]() |
![]() |
|||
105-P | WEVE ALL GONE THROUGH THE SAME JOURNEY: EFFECTIVENESS OF A MINDFULNESS-BASED RETREAT FOR MOTHERS OF PEDIATRIC HEART TRANSPLANT RECIPIENTS | Samantha Anthony | ![]() |
![]() |
|||
107-P | ADIPONECTIN / LEPTIN RATIO AS AN INDEX TO DETERMINE METABOLIC RISK IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Gra&328;ák | ![]() |
![]() |
|||
108-P | BLUEPRINTING EXTENDED REALITY AND TANGIBLE RESOURCES FOR SURGICAL EDUCATION; EXPERIENCES AND POTENTIALITIES FROM THE ENTICE PROJECT. | Panagiotis Antoniou | ![]() |
![]() |
|||
109-P | ADIPONECTIN / LEPTIN RATIO AS A PREDICTOR OF ACUTE REJECTION IN EARLY POST-TRANSPLANT PERIOD IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Granák | ![]() |
![]() |
|||
110-P | ANTICOAGULATION DECREASE THE VENOUS THROMBOSIS IN KIDNEY TRANSPLANTATION FROM UNCONTROLLED DONATION AFTER CARDIAC ARREST WITH HIGH RESISTANCE INDEX | María Molina | ![]() |
![]() |
|||
111-P | A PERSISTENT LEFT SUPERIOR VENA CAVA IN A PATIENT WITH RIGHT SUPERIOR VENA CAVA THROMBOSIS UNDERGOING EMERGENCY LT | Hana Kwoun | ![]() |
![]() |
|||
112-P | MULTIPLE ARTERY ANASTOMOSIS IN KIDNEY TRANSPLANTATION ; INTERNAL ILIAC ARTERY INTERPOSITION GRAFT | Jongpo Kim | ![]() |
![]() |
|||
113-P | USE OF NATIVE URETER IN RE-INTERVENTIONS AFTER KIDNEY TRANSPLANTATION | Edip Akpinar | ![]() |
![]() |
|||
114-P | INTRAOPERATIVE SOMATIC TISSUE OXYGEN SATURATION FOR DETECTING POSTOPERATIVE EARLY KIDNEY DYSFUNCTION PATIENTS UNDERGOING LDLT | Seunghee Cha | ![]() |
![]() |
|||
115-P | ORGAN DONATION: PROMOTING INTER-CULTURAL AND INTER-FAITH DIALOGUE | David Paredes-Zapata | ![]() |
![]() |
|||
117-P | THE USE OF HISTOPATHOLOGICAL FEATURES AS ENDPOINTS IN ACUTE T CELL-MEDIATED REJECTION (TCMR) RESPONSE IN RENAL ALLOGRAFTS | B. Handan Ozdemir | ![]() |
![]() |
|||
118-P | RENAL ALLOGRAFT BIOPSY FINDINGS IN PATIENTS WITH COVID-19 | B. Handan Ozdemir | ![]() |
![]() |
|||
120-P | PSYCHOSOCIAL ASSESSMENT AMONG DECEASED DONOR KIDNEY TRANSPLANTATION CANDIDATES IN SOUTH KOREA | Hye Jin Chong | ![]() |
![]() |
|||
121-P | DONOR, RECIPIENT AND SURGEON SEX AND SEX-CONCORDANCE AND THEIR IMPACT ON LIVER TRANSPLANT OUTCOME | Laura Mazilescu | ![]() |
![]() |
|||
123-P | PATIENT EXPERIENCE IN TRANSPLANTATION- A QUALITATIVE ANALYSIS USING FINDINGS OF THE ORGAN UTILISATION GROUP REPORT | Claire Williment | ![]() |
![]() |
|||
124-P | OUTCOME OF 40 LIVING DONOR LIVER TRANSPLANTATIONS IN A NEWLY ESTABLISHED ADULT LIVING DONOR LIVER TRANSPLANT PROGRAM IN THE NETHERLANDS | Alicia Chorley | ![]() |
![]() |
|||
126-P | POST REPERFUSION SYNDROME IN PEDIATRIC LIVER TRANSPLANTATION: EXPERIENCE OF A CENTER (LYON). | Catherine Boucaud-Le-Brun | ![]() |
![]() |
|||
128-P | THIS FAMILY AND THE GAMES ARE MY WORLD: CONCEPTUALISING THE BRITISH AND EUROPEAN TRANSPLANT GAMES AS THERAPEUTIC LANDSCAPES | Abbie Greig | ![]() |
![]() |
|||
129-P | EVALUATING OF THE BLOOD PRESSURE PROFILE AFTER KIDNEY TRANSPLANTATION | Seyf Eddine Nassim Sabri | ![]() |
![]() |
|||
130-P | FAMILY-CENTRED APPROACH FOR ORGAN DONATION AUTHORISATION: A GROUNDED THEORY STUDY | Lissette Aviles | ![]() |
![]() |
|||
131-P | POLYCYSTIC DISEASE: A CUMBERSOME INDICATION FOR TRANSPLANTATION | Alberto Calleri | ![]() |
![]() |
|||
132-P | ANALYSIS OF COVID19 CASES WITH RENAL TRANSPLANTATION (KTX): PREDICTIVE FACTIORS OF SEVERE DISEASE | Edip AKPINAR | ![]() |
![]() |
|||
133-P | ASSOCIATION BETWEEN TELOMERE LENGTH, MITOCHONDRIA DYSFUNCTION AND KLOTHO LEVELS IN KIDNEY TRANSPLANT RECIPIENTS | Woo Yeong Park | ![]() |
![]() |
|||
134-P | INCIDENCE OF MALIGNANCIES AFTER LUNG TRANSPLANTATION AND THEIR EFFECT ON OUTCOME. A 26 YEARS EXPERIENCE. | Konstantina Spetsotaki | ![]() |
![]() |
|||
135-P | LIVER TRANSPLANTATION AT THE KOREA UNIVERSITY : ANALYSIS OF 500 CASES AND INTRODUCING OUR UNIQUE MULTI-INSTITUTIONAL NETWORK | Young-Dong Yu | ![]() |
![]() |
|||
136-P | COMPARISON STUDY BETWEEN FULL THICKNESS AND ANTERIOR LAMELLAR CORNEAL XENOTRANSPLANTATION FROM SAME TRANGENIC PIGS TO MONKEY | Ik Jin Yun | ![]() |
![]() |
|||
137-P | CONTRAST ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY IN THE EARLY PERIOD AFTER RENAL TRANSPLANTATION | Ji-Il Kim | ![]() |
![]() |
|||
139-P | PASSENGER LYMPHOCYTE SYNDROME PRESENTED AS HEMOLYTIC ANEMIA AFTER SMALL BOWEL TRANSPLANTATION: A CASE REPORT | Jeongkye Hwang | ![]() |
![]() |
|||
141-P | PREDICTIVE MODEL OF TRANSPLANTED KIDNEY FUNCTION USING AUTOMATED COMPUTED TOMOGRAPHY VOLUMETRY | Dha Woon Im | ![]() |
![]() |
|||
142-P | LAPAROSCOPIC HAND-ASSISTED DONOR HEMINEPHRECTOMY IN LIVING DONOR WITH HORSESHOE KIDNEY (CASE PRESENTATION) | Islam Madadov | ![]() |
![]() |
|||
145-P | HEMOSTATIC PROTEIN PRODUCTION DURING LONG-TERM EX SITU NORMOTHERMIC MACHINE PERFUSION OF HUMAN DONOR LIVERS RESULTS IN PLASMA-LIKE PERFUSION FLUID | Bianca Lascaris | ![]() |
![]() |
|||
146-P | NO QUICK-FIX IN DETECTING SARCOPENIA IN PATIENTS ENLISTED FOR KIDNEY TRANSPLANTATION - MEASUREMENTS OF PSOAS MUSCLE | Hkon Heldal | ![]() |
![]() |
|||
147-P | UTILIZATION AND CLINICAL OUTCOMES OF SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION FROM OLDER PANCREAS DONORS. | Jeevan Gopal | ![]() |
![]() |
|||
149-P | IMPACT OF COVID-19 SAFETY MEASURES ON NON-COVID-19 INFECTIONS IN SOLID ORGAN TRANSPLANT PATIENTS DURING THE PANDEMIC; A SINGLE CENTRE STUDY. | Aeliya Zaidi | ![]() |
![]() |
|||
150-P | THE QUALITY OF LIFE OF LIVING LIVER DONORS POST-DONATION: AN AMBIDIRECTIONAL COHORT STUDY | Hayo ter Burg | ![]() |
![]() |
|||
151-P | SUCCESSFUL KIDNEY TRANSPLANTATION WITH ARTERIAL RECONSTRUCTION FROM A DECEASED DONOR WITH MARFANS SYNDROME A CASE REPORT. | Agnieszka Mizerska | ![]() |
![]() |
|||
152-P | PERIOPERATIVE TRANEXAMIC ACID IN RENAL TRANSPLANTATION WILL IT BLEED OR WILL IT CLOT? | Nader Bedwani | ![]() |
![]() |
|||
153-P | DIVERSITY OF CIRCULATING B CELL SUBSETS INRENAL TRANSPLANT RECIPIENTS EARLY POSTTRANSPLANT. | Ariadni Fouza | ![]() |
![]() |
|||
154-P | ATHEROSCLEROSIS AND INTRARENAL RESISTANCE INDEX IN KIDNEY TRANSPLANT RECIPIENTS | Tim Swaab | ![]() |
![]() |
|||
155-P | COVID-19 EFFECT ON KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE COHORT STUDY | Eleni Avramidou | ![]() |
![]() |
|||
158-P | THE EVACADE STUDY: DD-CFDNA FOR DIAGNOSIS OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION ON BEHALF OF THE SPANISH WORKING GROUP ON TRANSPLANT IMMUNOLOGY | Francisco Boix | ![]() |
![]() |
|||
159-P | NEUTROPHIL-TO-LYMPHOCYTE RATIO AND FRAILTY: HIGHLY PREDICTIVE TOOLS FOR CYTOMEGALOVIRUS INFECTIONS IN KIDNEY TRANSPLANT PATIENTS | Bing Jie Chow | ![]() |
![]() |
|||
160-P | THE IBOX SCORE AS A PREDICTIVE FACTOR IN A RETROSPECTIVE KIDNEY RETRANSPLANT COHORT | Valeria Wagner | ![]() |
![]() |
|||
161-P | EARLY GRAFT FUNCTION USING PREDICTED DONOR RENAL CORTICAL VOLUME WITH CT IMAGE ANALYSIS | Taiki Ogasa | ![]() |
![]() |
|||
162-P | SERIOUS ADVERSE REACTIONS AND SERIOUS ADVERSE EVENTS ANALYSIS IN ORGAN DONATION AND TRANSPLANTATION NETWORK FROM 2012 TO 2021 | Federica Domini | ![]() |
![]() |
|||
163-P | SCOPING REVIEW OF CURRENT DEVELOPMENTS OF RADIONOMICS IN KIDNEY TRANSPLANTATION | Jie Yen | ![]() |
![]() |
|||
164-P | FAILURE TO RESCUE RATE TO BETTER ANALYZE SURGICAL COMPLICATIONS AFTER 500 PEDIATRIC LIVING DONOR LIVER TRANSPLANTATIONS. | Aniss Channaoui | ![]() |
![]() |
|||
165-P | DONATION AFTER CARDIOCIRCULATORY DEATH IN PATIENTS OLDER THAN 70 YEARS | Ramón Mula Martínez | ![]() |
![]() |
|||
166-P | NAĎVE T CELL-DEPLETED HEMATOPOIETIC GRAFT COMBINED WITH SOLID ORGAN TRANSPLANTATION AS STRATEGY TO INDUCE TOLERANCE | Carlos Jimenez | ![]() |
![]() |
|||
167-P | MANAGEMENT OF BKV INFECTION AND NEPHROPATHY IN KIDNEY TRANPLANT RECIPIENTS; NINE YEARS OF EXPERIENCE | aglar Ruhi | ![]() |
![]() |
|||
169-P | ASSESSMENT OF DD-CFDNA IN KIDNEY TRANSPLANTATION AS A MARKER OF GRAFT INJURY A PROSPECTIVE STUDY | José Silvano | ![]() |
![]() |
|||
170-P | EX VIVO NORMOTHERMIC CIRCULATION (PNEV) OF GRAFTS FROM DCDS. AN EXPERIMENTAL STUDY OF BIOCHEMICAL AND METABOLIC CONDITION | Marina Mata | ![]() |
![]() |
|||
171-P | SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT IPSILATERAL VERSUS CONTRALATERAL, A SINGLE UNIT EXPERIENCE | Lorenzo Petagna | ![]() |
![]() |
|||
172-P | EARLY DETERMINATION OF FAST TACROLIMUS METABOLIZER STATUS IDENTIFY RISK OF REJECTION AND ALLOGRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS | Christophe Masset | ![]() |
![]() |
|||
173-P | EVOLUTION OF HUMORAL RESPONSE TO SARS-COV-2 VACCINATION AFTER KIDNEY TRANSPLANTATION IN PATIENTS PREVIOUSLY VACCINATED WHILE ON THE WAITING LIST | Christophe Masset | ![]() |
![]() |
|||
174-P | ASSOCIATION BETWEEN HLA MOLECULAR MISMATCH AND HISTOLOGICAL REJECTION IN KIDNEY ALLOGRAFT | Sook Park | ![]() |
![]() |
|||
175-P | METABOLIC ACIDOSIS INCREASES MORTALITY AND PROGRESSION OF CHRONIC GRAFT FAILURE IN PATIENTS LONG TERM AFTER KIDNEY TRANSPLANTATION | Marcin Adamczak | ![]() |
![]() |
|||
176-P | LIVER GRAFT REDUCTION THROUGH EX-VIVO RIGHT POSTERIOR SECTIONECTOMY: SINGLE CENTER EXPERIENCE IN PREVENTING LARGE-FOR-SIZE SYNDROME | Andrea Della Penn | ![]() |
![]() |
|||
177-P | EFFECT OF RECONSTRUCTION TYPE OF DUAL ARTERIES ON LONG-TERM OUTCOME IN LIVING DONOR KIDNEY TRANSPLANTATION | Won-Bae Chang | ![]() |
![]() |
|||
180-P | THE PREVALENCE OF DYSLIPIDEMIA BEFORE AND AFTER SUCCESSFUL LIVER TRANSPLANTATION | Marcin Adamczak | ![]() |
![]() |
|||
181-P | IMPACT OF HUANGS CLASSIFICATION ON MANAGEMENT OF BILIARY STRICTURES IN LIVING DONOR LIVER TRANSPLANTATION | Shahzad Riyaz | ![]() |
![]() |
|||
183-P | CLINICAL OUTCOME OF LUNG TRANSPLANTATION IN CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE | Hyeyoung Hong | ![]() |
![]() |
|||
184-P | 48HR NORMOTHERMIC MACHINE PERFUSION WITH URINE RECIRCULATION FOR DISCARDED HUMAN KIDNEY GRAFTS: A CASE SERIES | Franka Messner | ![]() |
![]() |
|||
185-P | THE QUESTIONABLE BURDEN OF AB0 INCOMPATIBLE KIDNEY TRANSPLANTATION | Caroline Berchtold | ![]() |
![]() |
|||
187-P | PLASMA FGF21 CONCENTRATION IN KIDNEY TRANSPLANT RECIPIENTS | Marcin Adamczak | ![]() |
![]() |
|||
189-P | INCREASED TACROLIMUS TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS WITH COVID-19 | Faiza Sebhi | ![]() |
![]() |
|||
190-P | THE OUTCOMES OF FISTULA TRACT EMBOLIZATION FOR ANASTOMOTIC BILIARY LEAKAGE AFTER LIVING DONOR LIVER TRANSPLANTATION | Hae Won Lee | ![]() |
![]() |
|||
191-P | DONORS AGE MODIFIES THE IMPACT OF PRE-DONATION ESTIMATED GLOMERULAR FILTRATION RATE ON CENSORED GRAFT SURVIVAL | Jorge Malheiro | ![]() |
![]() |
|||
192-P | URINARY LEVELS OF V-SET IG DOMAIN-CONTAINING 4 (VSIG4) ARE ASSOCIATED WITH CHRONIC CHANGES IN TRANSPLANT KIDNEYS | Sang Youb Han | ![]() |
![]() |
|||
196-P | FUNCTIONAL OUTCOMES AFTER ALEMTUZUMAB THERAPY FOR T-CELL MEDIATED, ANTIBODY-MEDIATED AND MIXED KIDNEY TRANSPLANT REJECTION | Lukas van Vugt | ![]() |
![]() |
|||
197-P | SYSTEMATIC REPORTING AND INVESTIGATION OF POSSIBLE INFECTION OF DONOR ORIGIN IN DECEASED ORGAN DONATION IS ESSENTIAL FOR BEST TRANSPLANTATION PRACTICE | Ines Ushiro-Lumb | ![]() |
![]() |
|||
198-P | EARLY RESULTS OF A SCREENING PROGRAM FOR SKIN CANCER IN LIVER TRANSPLANT RECIPIENTS: A COHORT STUDY | Dina Leth Mller | ![]() |
![]() |
|||
200-P | FACTORS THAT INFLUENCE THE DEVELOPMENT AND IMPLEMENTATION OF PREHABILITATION FOR KIDNEY TRANSPLANT CANDIDATES: A MIXED-METHODS CONTEXTUAL ANALYSIS | Avril Haanstra | ![]() |
![]() |
|||
203-P | PRE-TRANSPLANT PROPORTIONS OF POLYFUNCTIONAL DONOR-REACTIVE T CELLS ARE ASSOCIATED WITH ACUTE T-CELL MEDIATED REJECTION OF THE KIDNEY TRANSPLANT | Nicolle Litjens | ![]() |
![]() |
|||
205-P | VIGILANCE DATA IN ORGAN DONATION AND SOLID ORGAN TRANSPLANTATION IN GERMANY: DONOR-DERIVED DISEASE TRANSMISSION FROM 2016-2022. | Ana Paula Barreiros | ![]() |
![]() |
|||
206-P | MULTIPARAMETER ANALYSIS OF ALLOREACTIVE T CELLS IDENTIFIED BY ACTIVATION-INDUCED MARKERS (AIMS); DIFFERENT AIMS RECOGNIZE SPECIFIC T CELL SUBSETS | Nicolle Litjens | ![]() |
![]() |
|||
207-P | REMAINING STEROID FREE ONE YEAR AFTER KIDNEY TRANSPLANTATION | Lada Zibar | ![]() |
![]() |
|||
208-P | MICROSURGICAL ANASTOMOSIS BETWEEN LOWER POLAR ARTERY AND INFERIOR EPIGASTRIC ARTERY IN KIDNEY TRANSPLANT: SINGLE CENTRE EXPERIENCE | Matteo Zanchetta | ![]() |
![]() |
|||
209-P | INTRAOPERATIVE MEASURES OF VASCULAR FLOW IN LIVER TRANSPLANT. WHAT CAN THEY REALLY FORESEE? | María Arteaga Ledesma | ![]() |
![]() |
|||
210-P | PATIENTS EXPERIENCES OF PATHWAY CARE AFTER KIDNEY TRANSPLANTATION: FINDINGS FROM AN ITALIAN ETHNOGRAPHIC RESEARCH | Enrica Baraldi | ![]() |
![]() |
|||
211-P | MESENCHYMAL STEM CELLS INFUSION DURING LIVER RESECTION AND TRANSPLANTATION REGENERATION AUGMENTATION AND IMMUNE MODULATION: CASE REPORT | Denis Efimov | ![]() |
![]() |
|||
212-P | LONG-TERM PRESERVATION OF KIDNEYS BY MEANS OF CRYOPERFUSION: THE NEXT STEP IN ORGAN PRESERVATION? | Carolina Campos Pamplona | ![]() |
![]() |
|||
213-P | AWARENESS CAMPAIGN FOR ORGAN DONATION THROUGH SOCIAL MEDIA AND PODCASTS: AN INNOVATIVE APPROACH | Enrica Baraldi | ![]() |
![]() |
|||
214-P | HORMONAL PROFILE OF FEMALES INFLUENCES INTESTINAL REPERCUSSIONS IN POTENTIAL BRAIN-DEAD DONORS | Fernanda Yamamoto Ricardo da Silva | ![]() |
![]() |
|||
216-P | DONOR-DERIVED CELL-FREE DNA AND GENE EXPRESSION PROFILE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Maria Jose Ramirez-Bajo | ![]() |
![]() |
|||
217-P | SARCOPENIA BUT NOT FRAILTY IS ASSOCIATED WITH A SPECIFIC METABOLOMIC SIGNATURE IN KIDNEY TRANSPLANT CANDIDATES | Maria Jose Perez Saez | ![]() |
![]() |
|||
218-P | EFFICACY OF DESENSITIZATION IN HLA-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION | Marta Blanco Pardo | ![]() |
![]() |
|||
220-P | NEOPLASTIC COMPLICATIONS IN PATIENTS WITH LONG-TERM RENAL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE | Marco Busutti | ![]() |
![]() |
|||
221-P | EVALUATING THE USE OF CONTINUOUS GLUCOSE MONITORING (CGM) EARLY AFTER KIDNEY TRANSPLANTATION | Georgios Eleftheriadis | ![]() |
![]() |
|||
222-P | CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION IMPROVES RENAL FUNCTION: A SINGLE CENTER EXPERIENCE | Daniela Kniepeiss | ![]() |
![]() |
|||
224-P | PROGNOSTIC VALUE OF CREATININE REDUCTION RATIO AT POSTOPERATIVE DAY 2 AFTER KIDNEY TRANSPLANTATION | Florent Von Tokarski | ![]() |
![]() |
|||
225-P | OPTIMIZING PATIENT THRIVING DURING THE TRANSPLANT PROCESS | Camilla Nonterah | ![]() |
![]() |
|||
226-P | IS IMPLANTABLE DOPPLER PROBE USEFUL AS A VASCULAR MONITORING DEVICE IN KIDNEY TRANSPLANT PATIENTS: A RETROSPECTIVE COHORT, SINGLE CENTRE STUDY. | Shahzar Malik | ![]() |
![]() |
|||
227-P | PPI CONSULTATION ON THE PROTOCOL DEVELOPMENT OF A STUDY INVESTIGATING THE FEASIBILITY OF THE IMPLANTABLE DOPPLER PROBE IN KIDNEY TRANSPLANTATION | Shahzar Malik | ![]() |
![]() |
|||
228-P | COMPARISON OF COVID-19 AFTER KIDNEY TRANSPLANTATION BEFORE AND AFTER THE OMICRON VARIANT EPIDEMIC IN JAPAN | Kenta Futamura | ![]() |
![]() |
|||
229-P | URINE-DERIVED STEM CELL ATTENUATED RENAL FIBROSIS AFTER ISCHEMIA REPERFUSION VIA KLOTHO ACTIVATION | Jae Wan Jeon | ![]() |
![]() |
|||
230-P | DELETION OF PTP4A1 AMELIORATE RENAL FIBROSIS INDUCED BY UUO IN MICE. | Yunkyeong Hwang | ![]() |
![]() |
|||
231-P | THE LONG-TERM RISKS OF KIDNEY DONATION (RENAL RESERVE, HYPERTENSION): OBSERVATIONS FROM A 15-YEAR FOLLOW-UP PERIOD AT THE MILITARY MEDICAL ACADEMY | Jelena Tadic | ![]() |
![]() |
|||
232-P | PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS IN A BELGIAN COHORT OF LUNG TRANSPLANT CANDIDATES: THE PROGRESS STUDY | Edwin Curraj | ![]() |
![]() |
|||
233-P | REDUCTION OF ORGAN ALLOCATION TIMES | Federica Domini | ![]() |
![]() |
|||
234-P | FUTURE-PROOFING DECEASED DONOR KIDNEY TRANSPLANTATION: FIRST RESULTS OF A UNIQUE COLLABORATIVE BETWEEN FIVE TRANSPLANT CENTRES IN A METROPOLITAN AREA | Isaac Kim | ![]() |
![]() |
|||
235-P | EXTENDING THE USE OF WEB PORTAL FOEDUS TO UNITED KINGDOM ORGANIZATION (NHS) AND EUROTRANSPLANT IN 2022 | Federica Domini | ![]() |
![]() |
|||
236-P | ASSOCIATION BETWEEN ADULT DBD KIDNEY OFFER DECLINE RATES AND RISK-ADJUSTED WAITING TIMES IN THE UNITED KINGDOM | Lisa Mumford | ![]() |
![]() |
|||
238-P | THE EFFICACY OF FERROPTOSIS INHIBITION IN KIDNEY ISCHEMIA REPERFUSION INJURY AND TRANSPLANTATION: A SYSTEMATIC REVIEW | Lene Devos | ![]() |
![]() |
|||
239-P | REAL LIFE SINGLE-CENTRE EXPERIENCE IN PATIENTS WITH LONG-SURVIVAL RENAL TRANSPLANTATION | Marco Busutti | ![]() |
![]() |
|||
240-P | CARDIOVASCULAR EVENTS AFTER KIDNEY TRANSPLANTATION AND LONG-TERM OUTCOMES. | Elizabete Junk | ![]() |
![]() |
|||
241-P | MISMATCHED HUMAN LEUCOCYTE ANTIGENS BETWEEN BLOOD DONORS AND WAITLISTED TRANSPLANT PATIENTS LEADS TO TRANSFUSION SPECIFIC HLA-B ANTIBODIES | Katrina Spensley | ![]() |
![]() |
|||
242-P | PROGESTERONE EFFECTS ON INTESTINAL CHANGES CAUSED BY ISCHEMIA AND REPERFUSION PROCESS | Brunella Valbăo | ![]() |
![]() |
|||
243-P | KIDNEY QUALITY ASSESSMENT USING LASER SPECKLE CONTRAST IMAGING DURING NORMOTHERMIC MACHINE PERFUSION | Yitian Fang | ![]() |
![]() |
|||
245-P | THE EXPERIENCES OF HEALTH CARE PROFESSIONALS APPROACHING FAMILIES FOR ORGAN DONATION CONSENT: A MIXED-METHOD SYSTEMATIC REVIEW | Liset Pengel | ![]() |
![]() |
|||
246-P | NORMOTHERMIC MACHINE PERFUSION ALTERS RENAL GENE EXPRESSION PATTERNS | Veerle A. Lantinga | ![]() |
![]() |
|||
247-P | DEFINING THE STABILIZATION POINT OF KIDNEY FUNCTION FOLLOWING TRANSPLANTATION: AN OBSERVATIONAL COHORT STUDY | Evert Cleenders | ![]() |
![]() |
|||
248-P | Characterization of SARS-COV-2 spike-specific CD4 T-cells after mRNA-1273 vaccination in kidney and lung transplantation recipients | Céline Imhof | ![]() |
![]() |
|||
251-P | POST-LIVER TRANSPLANTATION RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS: ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | Luisa Pasulo | ![]() |
![]() |
|||
252-P | EXPLORING THE TRENDS IN SYSTEMATIC REVIEWS OF KIDNEY TRANSPLANTATION: A COMPREHENSIVE ANALYSIS OF THE EVIDENCE BASE OVER A DECADE | Sarah Salih | ![]() |
![]() |
|||
253-P | HUMORAL AND CELLULAR RESPONSE AFTER THE 3RD TOZINAMERAN DOSE IS ACCOMPANIED WITH ACTIVATION OF CERTAIN LYMPHOCYTE SUBPOPULATIONS | Asimina FYLAKTOU | ![]() |
![]() |
|||
254-P | HEMOCHROMATOSIS IN KIDNEY TRANSPLANT RECIPIENTS: CASE SERIES | SEDA SAFAK OZTURK | ![]() |
![]() |
|||
255-P | PORCINE PRECISION-CUT LIVER SLICES AS AN ACCOMPANYING MODEL TO STUDY PERFUSATE COMPOSITION DURING LONG-TERM LIVER NORMOTHERMIC PERFUSION | Julia Hofmann | ![]() |
![]() |
|||
256-P | ATYPICAL HAEMOLYTIC UREMIC SYNDROME (AHUS) RECURRENCE AFTER KIDNEY TRANSPLANTATION IN PATIENTS WITH ECULIZUMAB PROPHYLAXIS | Marta Blanco Pardo | ![]() |
![]() |
|||
257-P | HUMAN LIVER TRANSPLANTATION: EVALUATION OF IMMUNE T CELLS WITH TISSUE REPAIR FUNCTIONS | Bost Romain | ![]() |
![]() |
|||
258-P | TAILORED IMMUNOSUPPRESSION WITH LCP EXTENDED RELEASE TACROLIMUS BASED ON NFAT-REGULATED GENE EXPRESSION | Judith Kahn | ![]() |
![]() |
|||
260-P | TRACER METABOLOMICS DURING NORMOTHERMIC KIDNEY PERFUSION AS A NON-INVASIVE TOOL TO UNRAVEL WHOLE ORGAN KIDNEY METABOLISM | Julie De Beule | ![]() |
![]() |
|||
261-P | ISCHEMIA-INDUCED METABOLIC PATTERNS PREDICT KIDNEY FUNCTION DURING PIG NORMOTHERMIC PERFUSION | Julie De Beule | ![]() |
![]() |
|||
263-P | SAFETY AND BENEFIT OF A SMALL INCISION FOR DONOR HEPATECTOMY IN LIVING-DONOR LIVER TRANSPLANTATION | Hikaru Hayashi | ![]() |
![]() |
|||
265-P | INVESTIGATION OF STUDIES ON PHYSICAL ACTIVITY IN KIDNEY TRANSPLANT RECIPIENTS | Eda Ayten Kankaya | ![]() |
![]() |
|||
266-P | FIRST CLINICAL EXPERIENCE WITH TIXAGEVIMAB AND CILGAVIMAB IN LUNG TRANSPLANT RECIPIENTS DURING OMICRON WAVE | Peter Jaksch | ![]() |
![]() |
|||
268-P | HISTOLOGICAL SCREENING FOR BK POLYOMAVIRUS NEPHROPATHY FOLLOWING VIRAL REPLICATION IN PLASMA: AN OBSERVATIONAL COHORT STUDY | Evert Cleenders | ![]() |
![]() |
|||
269-P | PERI-OPERATIVE KINETICS OF PLASMA MITOCHONDRIAL DNA LEVELS DURING LIVING DONOR KIDNEY TRANSPLANTATION | Nora Spraakman | ![]() |
![]() |
|||
270-P | COVID-19 INFECTION IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS AFTER IMMUNIZATION WITH THE BNT162B2 COVID-19 MRNA VACCINE | Varvara Askiti | ![]() |
![]() |
|||
272-P | VALGANCICLOVIR VS LETERMOVIR PROPHYLAXIS AND RISK OF CYTOMEGALOVIRUS DNAEMIA IN A RANDOMIZED PHASE 3 TRIAL | Klemens Budde | ![]() |
![]() |
|||
273-P | A NEW KIDNEY OFFERING SCHEME IN THE UK - 3 YEAR REVIEW | Lisa Mumford | ![]() |
![]() |
|||
274-P | LONGITUDINAL DYNAMICS OF SARS-COV-2 SPIKE-SPECIFIC ANTIBODY RESPONSES IN PATIENTS ON WAITING LIST AND AFTER LUNG TRANSPLANTATION | Evgeny Chichelnitskiy | ![]() |
![]() |
|||
275-P | PATIENTS REFERRED TO RETRANSPLANTATION MAY BENEFIT FROM MAINTAINING CALCINEURIN INHIBITOR AFTER KIDNEY TRANSPLANT FAILURE | Kia Hakkarainen | ![]() |
![]() |
|||
277-P | THE PROSPECTIVE EFFECT OF LIVING AND DECEASED RELATED DONOR TRANSPLANTATIONS IN PATIENTS IMMUNE PROFILE | Asimina FYLAKTOU | ![]() |
![]() |
|||
278-P | LONG TERM SURVIVAL OF THE HEPATOCELLULAR CARCINOMA WITH OR WITHOUT LIVER TRANSPLANTATION | Emre KARAKAYA | ![]() |
![]() |
|||
279-P | TARGETED DELETION OF HYPOXIA INDUCIBLE TRANSCRIPTION FACTOR-1? GENE IN CD4 T CELLS IMPROVES VASCULARIZED COMPOSITE ALLOTRANSPLANTATION OUTCOME | Madonna Rica Anggelia | ![]() |
![]() |
|||
280-P | EFFECTS OF COLONIZATION WITH MULTIDRUG-RESISTANT BACTERIA ON PNEUMONIA ETIOLOGY IN THE FIRST YEAR AFTER KIDNEY AND HEART TRANSPLANTATION | Zrinka Bosnjak | ![]() |
![]() |
|||
281-P | DELAYED REGULATORY T CELL THERAPY FOLLOWING ALEMTUZUMAB INDUCTION | Conor Hennessy | ![]() |
![]() |
|||
282-P | A DEEP DIVE ON REAL-WORLD IMMUNOSUPRESSIVE THERAPY PATTERNS FOR RENAL TRANSPLANT PATIENTS IN FRANCE: 10 YEAR FOLLOW-UP DATA FROM THE OISTER STUDY | Dany Anglicheau | ![]() |
![]() |
|||
283-P | TOWARDS CREATING A FRAMEWORK FOR ENVIRONMENTAL SUSTAINABILITY IN KIDNEY TRANSPLANTATION SERVICES | Nikolaos-Andreas Anastasopoulos | ![]() |
![]() |
|||
284-P | FACTORS ASSOCIATED WITH GROWTH IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE, SINGLE-CENTER COHORT STUDY | VARVARA ASKITi | ![]() |
![]() |
|||
285-P | SHORT-TERM PREDICTIVE MODELS FOR POST-KIDNEY TRANSPLANT DIABETES MELLITUS USING MACHINE LEARNING APPROACH: PRELIMINARY DATA | Giae Yun | ![]() |
![]() |
|||
286-P | SILICONE DEPOSITIONS, AN UNUSUAL FINDING IN THE EXPLANTED AND NEWLY TRANSPLANTED LUNGS | Saskia Bos | ![]() |
![]() |
|||
287-P | CHARACTERISATION OF GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS | Conor Hennessy | ![]() |
![]() |
|||
290-P | ALPHA-1 ANTITRYPSIN DEFICIENCY IS UNDERDIAGNOSED IN CIRRHOTIC LIVER TRANSPLANT PATIENTS : A RETROSPECTIVE MULTICENTER STUDY | Audrey Coilly | ![]() |
![]() |
|||
291-P | STATE OF KNOWLEDGE OF ALPHA 1 ANTI-TRYPSIN DEFICIENCY AMONG PRACTITIONERS SPECIALIZED IN LIVER TRANSPLANTATION IN FRANCE : A NATIONAL SURVEY | Audrey Coilly | ![]() |
![]() |
|||
292-P | THE ROLE OFADIPOCYTOKINES IN DEVELOPMENT OF NEW ONSET DIABETES AFTER LIVER TRANSPLANTATION | Iva Kouta | ![]() |
![]() |
|||
293-P | ASSOCIATION BETWEEN PRETRANSPLANT DIALYSIS MODALITY AND LONG-TERM GRAFT OUTCOMES | Taehee Kim | ![]() |
![]() |
|||
294-P | CORRELATION OF DD-CFDNA AND REJECTION PHENOTYPES IN A BRAZILIAN PATIENT POPULATION | Helio Tedesco Silva Junior | ![]() |
![]() |
|||
296-P | THE IMPACT OF POSTREPERFUSION SYNDROME ON RECIPIENT MORTALITY AND GRAFT FAILURE IN LIVING DONOR LIVER TRANSPLANTATION | Seungwon Lee | ![]() |
![]() |
|||
298-P | EFFICACY AND SAFETY OF ECULIZUMAB FOR TREATMENT OF ANTIBODY-MEDIATED REJECTION FOLLOWING RENAL TRANSPLANTATION | Ho Sik Shin | ![]() |
![]() |
|||
299-P | CHARACTERIZING ADHERENCE PROFILES BASED ON C0 MONITORING IN KIDNEY TRANSPLANT PATIENTS: ILLUSION OR REALITY? | Caroline Monchaud | ![]() |
![]() |
|||
300-P | EVALUATION OF POST REPERFUSION BASELINE BIOPSIES FOR KIDNEY TRANSPLANT OUTCOME | Juan Carlos Torrez | ![]() |
![]() |
|||
301-P | A LENGTHENED EUTHANASIA ELIMINATES THE BURDEN OF ORGAN DONATION RELATED PREMORTEM INQUIRIES AND IN HOSPITAL PERFORMED EUTHANASIA. | Hans Sonneveld | ![]() |
![]() |
|||
302-P | PREGNANCY OUTCOMES AFTER LIVER AND KIDNEY TRANSPLANTATION | Emre KARAKAYA | ![]() |
![]() |
|||
303-P | UROLOGIC COMPLICATIONS AFTER KIDNEY TRANSPLANTATIONS AND THEIR MANAGEMENT | Emre KARAKAYA | ![]() |
![]() |
|||
304-P | Post COVID-19 condition is related to antibody levels after COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant | Reshwan Malahe | ![]() |
![]() |
|||
305-P | EFFECT OF A NATIONWIDE INTERVENTION TO REDUCE HEPATECTOMY TIMES IN DUTCH ORGAN PROCUREMENT TEAMS | Hanne Verberght | ![]() |
![]() |
|||
306-P | THE COST-EFFECTIVENESS OF PROPHYLAXIS IN CYTOMEGALOVIRUS SEROPOSITIVE (CMV R) KIDNEY TRANSPLANT RECIPIENTS OVER THE FIRST YEAR POST-TRANSPLANTATION | Villeneuve Claire | ![]() |
![]() |
|||
307-P | RENAL TRANSPLANTATION IN HYPERSENSITIZED PATIENTS. DESENSITIZATION VS. PATHI | Sara Doménica Erráez Guerrero | ![]() |
![]() |
|||
308-P | KIDNEY TRANSPLANTATION IN JEHOVAHS WITNESSES: ETHICAL IMPLICATIONS, MANAGEMENT PROPOSAL AND REVIEW OF LITERATURE | Marika Morabito | ![]() |
![]() |
|||
310-P | COMPARISON OF PERFUSATE COMPOSITION DURING NORMOTHERMIC LIVER PERFUSION - TRANSPLANTED VERSUS NON-TRANSPLANTED LIVERS | Jule Dingfelder | ![]() |
![]() |
|||
311-P | CLINICAL OUTCOMES OF DISTINCT INDUCTION THERAPIES IN LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANTS FROM CONTROLLED DONORS AFTER CIRCULATORY DEATH (CDCD) | Zaira Ivette Castańeda Amado | ![]() |
![]() |
|||
312-P | GPBAR-1/CAMP/PKA SIGNALLING MITIGATES THE MACROPHAGE-MEDIATED ACUTE CHOLESTATIC LIVER INJURY VIA ANTAGONIZING NLRP3-ASC INFLAMMASOME | Yunjie Lu | ![]() |
![]() |
|||
313-P | T LYMPHOCYTE SUBSETS IN LONG-TERM KIDNEY TRANSPLANT SURVIVORS | Efstratios Kasimatis | ![]() |
![]() |
|||
314-P | SHORT-TERM EFFECTS OF LOSARTAN TREATMENT IN ELDERLY PATIENTS AFTER KIDNEY TRANSPLANTATION AN INTERIM ANALYSIS OF CELART STUDY | Alicja Debska-Slizien | ![]() |
![]() |
|||
316-P | QUESTIONNAIRE FOR EXPLORING QUALITY OF LIFE FOLLOWING LIVER TRANSPLANTATION IN ROMANIAN PATIENTS | Speranta Iacob | ![]() |
![]() |
|||
320-P | Delayed graft function after kidney transplantation: The role of residual diuresis, oxalic acid, glyoxylic acid, and glycolic acid. | Gideon Post Hospers | ![]() |
![]() |
|||
321-P | Pregnancy after Kidney TransplantationImpact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity ofImmunosuppression on Kidney Function and Maternal Health | Mira Choi | ![]() |
![]() |
|||
322-P | COMPARISON BETWEEN INTERNAL ILIAC ARTERY AND EXTERNAL ILIAC ARTERY FOR RENAL ARTERY ANASTOMOSIS IN KIDNEY TRANSPLANTATION | Won-Bae Chang | ![]() |
![]() |
|||
323-P | SHORT-TERM HEPATITIS B IMMUNOGLOBULIN (HBIG) COMBINED WITH ENTECAVIR IN PREVENTING HBV RECURRENCE IN LIVER TRANSPLANTATION | Hao Zheng | ![]() |
![]() |
|||
324-P | ASSESSMENT OF COGNITIVE IMPAIRMENT IN KIDNEY TRANSPLANTATION AND ITS RELATED RISK FACTORS | Hristos Karakizlis | ![]() |
![]() |
|||
326-P | BELATACEPT IN RENAL TRANSPLANTATION: A REAL-WORLD PHARMACOKINETIC STUDY | Stephanie CHHUN | ![]() |
![]() |
|||
329-P | X-RAY ANALYSIS OF DONOR LUNGS IN EX-VIVO LUNG PERFUSION SYSTEM (EVLP). A PILOT STUDY WITH ASSESSMENT OF THE BRIXIA SCORE TO PREDICT TRANSPLANTABILITY. | Konstantina Spetsotaki | ![]() |
![]() |
|||
330-P | CAUSES FOR DISCARDING THE LIVING KIDNEY DONOR CANDIDATE: REVIEW OF THE LAST 20 YEARS AND 837 CANDIDATES | Mňnica Pérez Mir Pérez Mir | ![]() |
![]() |
|||
332-P | RISK MANAGEMENT AND SAFETY OF THE PEDIATRIC TRASPLANT PATIENT: THE ROLE OF THE NURSE IN THE PREPARATION OF THE CAREGIVER | Virginia Bove | ![]() |
![]() |
|||
334-P | DIALYSIS VINTAGE MATTERS: THE PROFOUND IMPACT OF DIALYSIS VINTAGE ON TRANSPLANT OUTCOMES. | Jan Lindeman | ![]() |
![]() |
|||
335-P | TREATMENT OF COMPLEX UROLITHIASIS IN ORTHOTOPIC KIDNEY TRANSPLANT BY ENDOSCOPIC COMBINED INTRARRENAL SURGERY (ECIRS) | Marina Mata | ![]() |
![]() |
|||
337-P | THE RISK FACTOR FOR DELAYED GRAFT FUNCTION IN THE DECEASED DONOR KIDNEY TRANSPLANTATION | Ju Ik Moon | ![]() |
![]() |
|||
339-P | ISCHEMIA-FREE KIDNEY TRANSPLANTATION: A PILOT STUDY | Guodong Chen | ![]() |
![]() |
|||
340-P | HLA INCOMPATIBILITY AND PANEL REACTIVE ANTIBODIES PRIOR TO RENAL TRANSPLANTATION CAN ADVERSELY AFFECT RENAL FUNCTION OUTCOME AND IMMUNE PROFILE | Asimina Fylaktou | ![]() |
![]() |
|||
341-P | EDTCO CONGRESS. ORGAN DONOR COORDINATORS LEADERSHIP IN ORGAN DONATION AND TRANSPLANTATION PRACTICE AND POLICY | Lissette Aviles | ![]() |
![]() |
|||
343-P | N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL AS A PREDICTOR OF ADVERSE RENAL AND CARDIOVASCULAR OUTCOMES IN STABLE RENAL TRANSPLANT RECIPIENTS. | Klemens Budde | ![]() |
![]() |
|||
345-P | MINIMALLY INVASIVE INGUINAL APPROACH IN KIDNEY TRANSPLANT SURGERY BRINGS EXCELLENT OUTCOMES | Rostand Emmanuel Nguefouet Momo | ![]() |
![]() |
|||
346-P | A NOVEL APPROACH USING BACTERIOPHAGE FOR MULTI-DRUG RESISTANT BURKHOLDERIA GLADIOLI IN A POST-LUNG TRANSPLANT PATIENT | Graham Hantman | ![]() |
![]() |
|||
347-P | A FEASIBILITY STUDY EXPLORING THE IMPACT OF A LOW ADVANCED GLYCATION END-PRODUCT DIET ON SKIN AUTOFLUORESCENCE IN KIDNEY TRANSPLANT RECIPIENTS. | Catherine Johnson | ![]() |
![]() |
|||
348-P | MANAGING THE DEFECT IN THE RIGHT RENAL VEIN IN DECEASED DONOR ORGAN PROCUREMENT: A SINGLE CENTRE EXPERIENCE. | Rostand Emmanuel Nguefouet Momo | ![]() |
![]() |
|||
349-P | EXTENDED RELEASE TACROLIMUS IN SIMULTANEUS KIDNEY PANCREAS TRANSPLANTATION (SKPT). PRELIMINARY RESULTS OF A PROSPECTIVE STUDY. | Giuseppe Iaria | ![]() |
![]() |
|||
350-P | EVALUATION OF DONORS QUALITY OF LIFE AFTER KIDNEY DONATION: SINGLE CENTER EXPERIENCE | Maria Smyrli | ![]() |
![]() |
|||
351-P | Haemodynamics in the external iliac artery: The utility of phase-contrast magnetic resonance angiography for investigating transplant renal artery stenosis | Paul Martin | ![]() |
![]() |
|||
352-P | IMPACT OF PEG35-BASED SOLUTION ON STEATOTIC LIVER COLD PRESERVATION: INSIGHTS INTO MITOCHONDRIAL PROTECTION AND CELL SIGNALING | Arnau Panisello Rosello | ![]() |
![]() |
|||
353-P | VAR-T CELLS: AN INNOVATIVE CELLULAR PLATFORM TO OPTIMIZE THE RESPONSE OF TRANSPLANTED PATIENTS ON THERAPEUTIC IMMUNOSUPPRESSION TO VACCINATION | Rim Hussein-Agha | ![]() |
![]() |
|||
355-P | POST-TRANSPLANT THROMBOTIC MICROANGIOPATHY (PT-TMA) AFTER ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION: TWO CASES WITH LOW ISOAGGLUTININ TITLES. | Jorge Malheiro | ![]() |
![]() |
|||
356-P | PERFUSATE FROM NORMOTHERMIC MACHINE PERFUSED DISCARDED HUMAN DONOR KIDNEYS HAS AN ANTI-INFLAMMATORY EFFECT ON MONOCYTE-DERIVED DENDRITIC CELLS | Laura Knijff | ![]() |
![]() |
|||
357-P | DESENSITIZATION WITH IMLIFIDASE IN CROSSMATCH-POSITIVE, HIGHLY SENSITIZED KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-CENTER EXPERIENCE | Stathis Tsiakas | ![]() |
![]() |
|||
358-P | LUMINAL INTESTINAL PRESERVATION FOLLOWING BRAIN DEATH MAY REDUCE INNATE IMMUNE SYSTEM ACTIVATION. | Marc Gjern Weiss | ![]() |
![]() |
|||
359-P | ANASTOMOTIC BILIARY LEAKAGE AFTER HEPATICOJEJUNOSTOMY IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION INCIDENCE, MANAGEMENT AND OUTCOME. | Mateusz Ciopi&324;ski | ![]() |
![]() |
|||
360-P | REDUCED CARDIOVASCULAR DISEASE ASSESSMENT FOR KIDNEY TRANSPLANT RECIPIENTS- A RETROSPECTIVE COHORT STUDY. | Michael Corr | ![]() |
![]() |
|||
361-P | INCIDENCE OF ANTIBODIES AGAINST HUMAN NEUTROPHIL ANTIGENS-3A IN KIDNEY TRANSPLANT CANDIDATES | Angeliki Vittoraki | ![]() |
![]() |
|||
362-P | THE IMPACT OF APPLYING UCSF CRITERIA TO PATIENTS UNDERWENT LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN A LOW VOLUME CENTER | Yeon Ho Park | ![]() |
![]() |
|||
363-P | A NOMOGRAM FOR PREDICTING MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER KIDNEY TRANSPLANTATION | Guodong Chen | ![]() |
![]() |
|||
364-P | THE OUTCOMES OF BK VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS; SINGLE CENTRE EXPERIENCE | Ahmed Saleh | ![]() |
![]() |
|||
365-P | THE METHOD OF USING ROBOTIC HARMONIC ULTRASONIC SHEAR FOR PARENCHYMAL TRANSECTION IN ROBOTIC DONOR RIGHT HEPATECTOMY | KWAN WOO KIM | ![]() |
![]() |
|||
367-P | COMPARISON IN ANALGESIC EFFICACY BETWEEN NEFOPAM AND ACETAMINOPHEN IN LIVING KIDNEY DONOR | Jaehee Seo | ![]() |
![]() |
|||
370-P | IMMUNOSUPRESSIVE TREATMENT AND CD4/CD8 T-CELL EXHAUSTION IMPACT SARS-COV-2-SPECIFIC ADAPTIVE RESPONSES AFTER VACCINATION IN SOLID ORGAN TRANSPLANT | Laura Donadeu | ![]() |
![]() |
|||
371-P | A CASE OF ISOLATED KIDNEY TRANSPLANTATION IN A PATIENT WITH PRIMARY HYPEROXALURIA TYPE 1 RECEIVING LUMASIRAN THERAPY | Maria Ilaria Moretti | ![]() |
![]() |
|||
372-P | CIRCULATING IRISIN LEVELS IN KIDNEY TRANSPLANT PATIENTS. | Alicja D&281;bska-&346;lizei&324; | ![]() |
![]() |
|||
377-P | DISPARITIES IN ORGAN DONATION RATES INSIDE THE EUROPEAN REGION | Brian Alvarez | ![]() |
![]() |
|||
378-P | MANAGEMENT OF INCISIONAL HERNIA FOLLOWING ABDOMINAL ORGAN TRANSPLANTATION | Vassilios Papalois | ![]() |
![]() |
|||
379-P | TRANSPLANTATION OF UNCONTROLLED DCD KIDNEYS AFTER RECONDITIONING BY A NOVEL EX-VIVO PERFUSION METHOD - REVIVEME TRIAL | Deepti Antony | ![]() |
![]() |
|||
380-P | PRO-INFLAMMATORY PROFILE OF ADIPOKINES IN KIDNEY TRANSPLANT RECIPIENTS | Alicja Debska-Slizien | ![]() |
![]() |
|||
381-P | PROTOCOL BIOPSY IN LIVING KIDNEY DONOR TRANSPLANTATION. | Khadidja Habchi | ![]() |
![]() |
|||
382-P | SHOULD INFECTION IN DECEASED ORGAN DONORS INHIBIT THE DECISION FOR KIDNEY TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE | Dionysios Prevezanos | ![]() |
![]() |
|||
385-P | COMPARISON OF PROGNOSIS AND RISK FACTORS OF GRAFT FAILURE BETWEEN PEDIATRIC AND ADULT RECIPIENTS WHO RECEIVED PEDIATRIC DONOR KIDNEY TRANSPLANTATION | Guodong Chen | ![]() |
![]() |
|||
386-P | DEVELOPMENT OF RENAL ALLOGRAFT LYMPHANGIECTASIA AFTER 14 YEARS FROM KIDNEY TRANSPLANTATION | Hae Won Park | ![]() |
![]() |
|||
387-P | LONG-TERM OUTCOME OF PEDIATRIC LIVER TRANSPLANTS: THE IMMUNOSUPPRESION AND PSYCHO-SOCIAL DEVELOPMENT | Rey-Heng Hu | ![]() |
![]() |
|||
390-P | PREVALENCE OF EARLY ACHIEVEMENT OF THERAPEUTIC LEVEL OF MYCOPHENOLATE AFTER A LOADING PROTOCOL AMONG THAI KIDNEY TRANSPLANT RECIPIENTS | Nuttasith Larpparisuth | ![]() |
![]() |
|||
391-P | PREGNANCY AFTER LUNG TRANSPLANTATION IN THE NETHERLANDS | Jildau Meinderts | ![]() |
![]() |
|||
393-P | EARLY COMPLICATIONS AFTER DESENSITIZED LIVING DONOR KIDNEY TRANSPLANTATION: ANALYSIS OF KOREAN ORGAN TRANSPLANTATION REGISTRY (KOTRY) DATA | Myeonghyeon Ko | ![]() |
![]() |
|||
394-P | KOMPARTE. REGISTERING MORE AND BETTER THE DONATION PROCESS | Alberto Sandiumenge | ![]() |
![]() |
|||
395-P | ROBOT ASSISTED RETROPERITONEOSCOPIC DONOR NEPHRECTOMY | Emin Baris Akin | ![]() |
![]() |
|||
396-P | A NATIONAL SURVEY OF CURRENT PERIOPERATIVE PRACTICES IN LIVER TRANSPLANTATION. Are we ready for enhanced recovery? | Carrie Scuffell | ![]() |
![]() |
|||
397-P | EPIDEMIOLOGY OF CANCER AFTER SOLID ORGAN TRANSPLANTATION (EPCOT): AN ENGLISH POPULATION-COHORT PROJECT OF LINKED NATIONAL DATASETS | Charlotte Stephens | ![]() |
![]() |
|||
398-P | Hyperreduced Left Lateral Living Donor Liver Transplant in a 4.5 kg Child - A First in Africa | Francisca van der Schyff | ![]() |
![]() |
|||
399-P | BLUE KIDNEY, A CHALLENGING CASE FOR LIVING DONOR KIDNEY TRANSPLANTATION | Ala Elcircevi | ![]() |
![]() |
|||
400-P | TISSUE DONATION ACTIVITY OF A THIRD LEVEL HOSPITAL ACCORDING TO THE NEW DEFINITIONS ESTABLISHED BY THE CRITICAL PATHWAY | Alberto Sandiumenge | ![]() |
![]() |
|||
401-P | ORGAN DONATION AFTER CIRCULATORY DEATH SHALL WE? PERCEPTIONS AND CHALLENGES OF GREEK NURSING PROFESSIONALS - A FOCUS GROUP STUDY | Christina Papachristou | ![]() |
![]() |
|||
402-P | CC GENOTYPE OF GNAS C.393CT (RS7121) POLYMORPHISM HAS A PROTECTIVE EFFECT AGAINST DEVELOPMENT OF BK VIREMIA AND BKV-ASSOCIATED NEPHROPATHY | Justa Friebus-Kardash | ![]() |
![]() |
|||
403-P | GNB3 C.825CT (RS5443) POLYMORPHISM AND RISK OF ACUTE CARDIOVASCULAR EVENTS AFTER RENAL ALLOGRAFT TRANSPLANT | Justa Friebus-Kardash | ![]() |
![]() |
|||
404-P | KIDNEY TRANSPLANT RECIPIENTS IN WHOM CONCENTRATION-CONTROLLED DOSE ADJUSTMENT OF MMF WAS PERFORMED HAD HIGHER REJECTION-FREE SURVIVAL AT THREE YEARS | Alexandre Garnier | ![]() |
![]() |
|||
405-P | THE SF12 IS SHORTER AND AS EFFICIENT AS SF36 TO EVALUATE HEATH QUALITY OF LIFE IN KIDNEY TRANSPLANT PATIENTS. | Villeneuve Claire | ![]() |
![]() |
|||
406-P | Association of Viral Infection, HLA-Immunization and long-term Graft Survival | Milena Tempel | ![]() |
![]() |
|||
407-P | EVALUATION OF THE BENEFIT OF PHARMACEUTICAL INTERVIEWS (PI) FOR DE NOVO KIDNEY TRANSPLANT PATIENTS AT 6 MONTHS. | Malissa Boucida | ![]() |
![]() |
|||
409-P | GLOBAL BURDEN OF IMMUNOSUPPRESSION AND ITS ASSOCIATION WITH BKV MORBIDITY IN ABOI VS. PRE-TRANSPLANT DSA-POSITIVE KIDNEY TRANSPLANT RECIPIENTS | Michael Eder | ![]() |
![]() |
|||
411-P | PROTEINURIA AND TYPE OF ALLOGRAFT INJURY IDENTIFY KIDNEY TRANSPLANT RECIPIENTS BENEFITING MOST FROM BELATACEPT CONVERSION | Thomas Schachxtner | ![]() |
![]() |
|||
412-P | VITALISE-PILOT, A FEASIBILITY PROJECT: EX VIVO OPTIMISATION OF DONOR LUNGS WITH INHALED SEVOFLURANE DURING NORMOTHERMIC EX VIVO LUNG PERFUSION | Shuqi Yang | ![]() |
![]() |
|||
413-P | SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION AND ITS EFFECT ON BONE | Simona Kratochvílová | ![]() |
![]() |
|||
415-P | NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH INDICATION AND FOLLOW-UP GRAFT BIOPSIES AT ONE AND THREE YEARS | Eulŕlia Solŕ Porta | ![]() |
![]() |
|||
416-P | RESTING LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION CAUSING CRITICAL ILLNESS, TO TRANSPLANT OR NOT TO TRANSPLANT? | Roy Baskin | ![]() |
![]() |
|||
417-P | FACTORS ASSOCIATED WITH PREMATURE LOSS OF KIDNEY GRAFTS FROM OLDER DONORS | Betty Chamoun Huacón | ![]() |
![]() |
|||
418-P | FACTORS ASSOCIATED WITH HEALTH RELATED QUALITY OF LIFE IN A GREEK COHORT OF KIDNEY TRANSPLANT RECIPIENTS: A PROSPECTIVE STUDY | Vasileios Koutlas | ![]() |
![]() |
|||
420-P | FROM PALLIATION TO FULL-TIME OCCUPATION: CYSTIC FIBROSIS PATIENT WITH BURKHOLDERIA CEPACIA COMPLEX ON ECMO SURVIVES LUNG TRANSPLANT AND BASAL MENINGITIS | Macé Schuurmans | ![]() |
![]() |
|||
421-P | Effect of Maternal Living Donor Liver Grafts in Rates of Rejection and Graft Loss | Francisca van der Schyff | ![]() |
![]() |
|||
422-P | REMARKABLE MORTALITY BEFORE LIVER TRANSPLANT IN BILIARY ATRESIA; PRELIMINARY OUTCOMES FROM A 14-YEAR COHORT STUDY | Amirali Mashhadiagha | ![]() |
![]() |
|||
423-P | THE INFLUENCE OF ANTIBODIES AGAINST MICA ON THE OUTCOME OF KIDNEY TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY | Ioannis Bellos | ![]() |
![]() |
|||
425-P | INFECTION, VACCINATION OR BOTH? THE SARS-COV-2 IMMUNE FOLLOW-UP OF KIDNEY AND LIVER TRANSPLANT RECIPIENTS. | Krzysztof Mucha | ![]() |
![]() |
|||
426-P | TRANSCRIPTIONAL PROFILES IN BLOOD AND URINE FROM KIDNEY TRANSPLANT PATIENTS WITH REJECTION AND GRAFT ACCEPTANCE | Cristian Alvarez | ![]() |
![]() |
|||
427-P | THE INFLUENCE OF ANTIBODIES AGAINST ANGIOTENSIN II TYPE-1 RECEPTOR ON THE OUTCOME OF KIDNEY TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY | Kalliopi Vallianou | ![]() |
![]() |
|||
429-P | Recovery from severe heart failure after lumasiran, pyridoxine, and isolated kidney transplantation in primary hyperoxaluria type 1 | Mira Choi | ![]() |
![]() |
|||
430-P | THE MINIMIZATION OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: A 3-YEAR PATIENT FOLLOW UP. | Emilia Kniola | ![]() |
![]() |
|||
431-P | CROSS-PLATFORM VALIDATION OF MOLECULAR MARKERS FOR REJECTION PHENOTYPES AFTER KIDNEY TRANSPLANTATION | Jasper Callemeyn | ![]() |
![]() |
|||
432-P | DE NOVO FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN THE KIDNEY ALLOGRAFT: ONE LESION, DIFFERENT OUTCOMES | Marion RABANT | ![]() |
![]() |
|||
433-P | DONOR-DERIVED CELL-FREE DNA IDENTIFIES TROUBLED KIDNEY ALLOGRAFTS. | Emilio Rodrigo | ![]() |
![]() |
|||
434-P | AGILE DATA JOURNEY AND GOVERNANCE TO LEVERAGE DIGITAL TRANSFORMATION OF A KIDNEY TRANSPLANT CENTER IN COLOMBIA | Andrea Garci Lopez | ![]() |
![]() |
|||
435-P | EDUCATION ON DIGITAL TRANSFORMATION: A PRIORITY TO MAXIMIZE ITS BENEFITS AND USES. EXPERIENCE OF A SINGLE CENTER IN LATIN AMERICA. | Andrea Garcia Lopez | ![]() |
![]() |
|||
436-P | TECHNICAL FAILURE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: INCIDENCE AND PREDICTORS FROM THE LARGEST PORTUGUESE CENTER OVER 20-YEARS | Bruno José Fraga Dias | ![]() |
![]() |
|||
437-P | SAFETY PROFILE OF SGLT2 INHIBITORS IN RENAL TRANSPLANT PATIENTS | caroline dudreuilh | ![]() |
![]() |
|||
439-P | NURSING EXPERIENCE WITH TELEMEDICINE DURING THE COVID-19 PANDEMIC IN THE CARE OF PATIENTS AFTER LIVER TRANSPLANTATION | Ilka Boin | ![]() |
![]() |
|||
440-P | PREDICTING INDEX FOR OUTCOMES AFTER DECEASED DONOR LIVER TRANSPLANT | Jiyoung Baik | ![]() |
![]() |
|||
442-P | DISCREPANCY BETWEEN PULMONARY ARTERY CATHETER AND CO-OXIMETRY VALUE OF MIXED VENOUS OXYGEN SATURATION DURING LIVER TRANSPLANTATION | Gaabsoo Kim | ![]() |
![]() |
|||
445-P | THE EFFECT OF STEROID PULSE THERAPY FOR THE REDUCTION OF ACUTE REJECTION EPISODE IN SUBCLINICAL BORDERLINE CHANGES : AN OPEN-LABEL, RANDOMIZED TRIAL | Hyunjung Ryu | ![]() |
![]() |
|||
447-P | IMMUNOLOGIC RESPONSE TO SARS-COV-2 VACCINATION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. | Nikoleta Printza | ![]() |
![]() |
|||
448-P | IMPACT OF NONSPECIFIC ALLOGRAFT BIOPSY FINDINGS IN SYMPTOMATIC KIDNEY TRANSPLANT RECIPIENTS | Bon Jin Koo | ![]() |
![]() |
|||
449-P | DELAYED GRAFT FUNCTION EFFECT ON T CELL SUBPOPULATIONS FOLLOWING RENAL TRANSPLANTATION | Efstratios Kasimatis | ![]() |
![]() |
|||
450-P | HAPLOIDENTICAL HSCT WITH KIR GENOTYPE MISMATCHED: DIMINISHED RISK OF MORTALITY, DISEASE-FREE MORTALITY AND ACUTE GVHD | Marlon Castrillon Álvarez | ![]() |
![]() |
|||
451-P | CIRCULATING IMMUNE CELL SUBSETS CORRELATE WITH INDICES OF LEFT VENTRICULAR FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS WITHOUT CARDIOVASCULAR DISEASE. | EVANGELIA DOUNOUSI | ![]() |
![]() |
|||
452-P | EVALUATION OF A READY-TO-USE AND FULLY AUTOMATED REAL-TIME PCR TO DETECT 11 VIRUSES IN HUMAN SAMPLES | Maria Avelia De Lorenzis | ![]() |
![]() |
|||
453-P | IMMUNE CELL REPERTOIRE IN KIDNEY TRANSPLANT BIOPSIES CLASSIFIED AS ACUTE REJECTION | Marian Clahsen-van Groningen | ![]() |
![]() |
|||
454-P | DEVELOPMENT OF A PARATHYROID CELL THERAPY ADAPTED FOR ALLO- AND XENO- TRANSPLANTATION FOR THE TREATMENT OF HYPOPARATHYROIDISM. | Mehdi Maanaoui | ![]() |
![]() |
|||
455-P | PRELIMINARY RESULTS OF INTRAOPERATIVE VASCULAR FLOW ASSESSMENT IN KIDNEY TRANSPLANTATION | Gianluca Rompianesi | ![]() |
![]() |
|||
456-P | FRACTION OF EXHALED NITRIC OXIDE IN LIVER TRANSPLANT RECIPIENTS AND MATCHED CONTROLS | Nicoline Stender Arentoft | ![]() |
![]() |
|||
457-P | Modelling changes in the pharmacokinetics of tacrolimus during pregnancy after kidney transplantation: A retrospective cohort study | Maaike Schagen | ![]() |
![]() |
|||
458-P | PERSON-CENTERED APPROACH IN DESIGNING A LEAN LIVING DONOR KIDNEY TRANSPLANT PATH: ADD VALUE OF IMPROVEMENT TOOLS | Rubba Fabiana | ![]() |
![]() |
|||
460-P | THE PROGNOSTIC VALUE OF LYMPHOCYTE SUBSETS IN ANTIBODY RESPONSE AFTER SARS-COV2 VACCINATION IN DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS. | Ioannis Mallioras | ![]() |
![]() |
|||
461-P | NATURAL KILLER CELLS BEFORE KIDNEY TRANSPLANTATION INVOLVED WITH OPPORTUNISTIC INFECTION. | Marie Matignon | ![]() |
![]() |
|||
462-P | PREVALENCE OF PERIPHERAL ARTERY DISEASE IN LIVER TRANSPLANT RECIPIENTS | Nicoline Stender Arentoft | ![]() |
![]() |
|||
465-P | AMBULATORY BLOOD PRESSURE MONITORING PRIOR TO KIDNEY DONATION | Lilia Ben Fatma | ![]() |
![]() |
|||
468-P | LUNG FUNCTION AFTER THORACO-ABDOMINAL NORMOTHERMIC REGIONAL PERFUSION IN A PORCINE DCD MODEL | Michiel Hu | ![]() |
![]() |
|||
474-P | HISTOLOGICAL ANALYSIS OF EXPRESSION OF AT1R, ETAR AND ADHESION MOLECULES IN PEDIATRIC KIDNEY TRANSPLANT PROTOCOL BIOPSIES | Elisa Benetti | ![]() |
![]() |
|||
475-P | SUCCESSFUL DESENSITIZATION WITH IMLIFIDASE AND DARATUMUAB IN A HIGHLY IMMUNIZED, CROSSMATCH POSITIVE LIVING-DONOR RE-TRANSPLANT RECIPIENT | Fabian Halleck | ![]() |
![]() |
|||
476-P | IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND PREVENTION OF SUDDEN CARDIAC DEATH IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Juric | ![]() |
![]() |
|||
478-P | HLA-DQ MISMATCHING AND RENAL TRANSPLANT OUTCOMES IN THE UK | Hatem Ali | ![]() |
![]() |
|||
479-P | HIGHEST RESPONSE RATES OF VECTOR CONTAINING REGIMENS AFTER FOUR DOSES OF COVID-19 VACCINES IN RENAL TRANSPLANT RECIPIENTS | Tina Schmidt | ![]() |
![]() |
|||
480-P | DIAGNOSTIC POTENTIAL OF SEQUENCING BASED T CELL ANALYSIS IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE | Nina Babel | ![]() |
![]() |
|||
481-P | ENDOVASCULAR TREATMENT OF RESISTANT RENOVASCULAR HYPERTENSION IN A PATIENT WITH MIDDLE AORTIC SYNDROME (CLINICAL CASE) | Stepan Sakhovskiy | ![]() |
![]() |
|||
482-P | LONGITUDINAL ANALYSIS OF PERIPHERAL BLOOD IMMUNE CELL SUBSETS IN KIDNEY TRANSPLANT RECIPIENTS AND CLINICAL CORRELATIONS A PROSPECTIVE STUDY. | EVANGELIA DOUNOUSI | ![]() |
![]() |
|||
483-P | RESULTS OF NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH PROVIDED BY A MOBILE ECMO TEAM ACROSS THE REGION OF MADRID | Nuria Martinez Sanz | ![]() |
![]() |
|||
484-P | IMPACT OF CONVERSION OF TWICE-DAILY TACROLIMUS TO ONCE-DAILY EXTENDED-RELEASE MELTDOSE TACROLIMUS ON CELLULAR IMMUNITY | Nina Babel | ![]() |
![]() |
|||
485-P | PERFORMANCE OF DIFFERENT ESTIMATED GLOMERULAR FILTRATION RATE EQUATIONS IN PREDICTING END-STAGE KIDNEY DISEASE EARLY AFTER LIVER TRANSPLANTATION | Tuija Innanen | ![]() |
![]() |
|||
486-P | NOVEL ANTIBODIES TO TARGET THE MEMBRANE ATTACK COMPLEX IN TREATING KIDNEY ISCHAEMIA REPERFUSION INJURY | Aeliya Zaidi | ![]() |
![]() |
|||
488-P | STRONGEST IMMUNOGENICITY OF HETEROLOGOUS COVID-19 VECTOR/MRNA VACCINATION IN COMPARISON TO HOMOLOGOUS REGIMENS IN KIDNEY AND LUNG RECIPIENTS | Tina Schmidt | ![]() |
![]() |
|||
489-P | IMPACT OF IMMUNOSSUPRESSION WITHDRAWAL IN DONOR(HLA)-SPECIFIC MEMORY B CELL RESPONSES IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS | Alba Torija Recasens | ![]() |
![]() |
|||
491-P | THE CLINICAL RELEVANCE OF BONE MARROW BIOPSY IN SOLID ORGAN TRANSPLANT RECIPIENTS. | Krzysztof Mucha | ![]() |
![]() |
|||
493-P | HIGH INCIDENCE AND VIRAL LOAD OF HHV-6A IN A MULTI-CENTRE KIDNEY TRANSPLANT COHORT | Nina Babel | ![]() |
![]() |
|||
494-P | Nutrient supplementation during Normothermic Machine Perfusion may be beneficial for support of the mitochondrial metabolism | Dafni Efraimoglou | ![]() |
![]() |
|||
495-P | TRANSEUROPEAN EDUCATIONAL INITIATIVE IN ORGAN DONATION AND TRANSPLANTATION | Chloe Balleste | ![]() |
![]() |
|||
496-P | OPPOSITE EFFECTS IN FRACTIONAL DONOR-DERIVED CELL-FREE DNA FROM URINE AND PLASMA IN KIDNEY RECIPIENTS? RESULTS FROM A PILOT STUDY. | Fanny Sandberg | ![]() |
![]() |
|||
497-P | URINARY BIOMARKERS IN A LIVING DONOR KIDNEY TRANSPLANTATION COHORT PREDICTIVE VALUE ON EARLY AND LONG-TERM GRAFT FUNCTION. | Nora Spraakman | ![]() |
![]() |
|||
499-P | MULTIMODAL REMOTE HOME-MONITORING OF LUNG TRANSPLANT RECIPIENTS DURING COVID-19 VACCINATIONS: PILOT STUDY OF THE COVIDA DESK | Macé Schuurmans | ![]() |
![]() |
|||
500-P | COVID-19: ROLE OF RESILIENCE ON THE PSYCHOLOGICAL IMPACT OF LOCKDOWN IN LIVER TRANSPLANT TRANSITIONAL CANDIDATES AND RECIPIENTS | Luisa Pasulo | ![]() |
![]() |
|||
501-P | RISK AND PROGNOSTIC FACTORS FOR POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS A POLISH MULTICENTER STUDY. | Krzysztof Mucha | ![]() |
![]() |
|||
502-P | LUNG PRESERVATION AT 4C TO 8C WITH A NOVEL LUNG STORAGE DEVICE: FIRST EUROPEAN EXPERIENCE | An-Lies Provoost | ![]() |
![]() |
|||
503-P | PUSHING THE BOUNDARIES OF DELISTING UNACCEPTABLE HLA IN HIGHLY SENSITISED PATIENTS IN CONTEXT OF NOVEL DESENSITISATION - USING C1Q ASSAY | Riddhi Singh | ![]() |
![]() |
|||
505-P | EFFECT OF (MICRO)THROMBI IN DONOR LUNGS ON LUNG FUNCTION DURING EX VIVO LUNG PERFUSION AND POST-OPERATIVE OUTCOMES | Michiel Hu | ![]() |
![]() |
|||
506-P | DONOR QUALITY OF LIFE AND PSYCHOSOCIAL OUTCOMES AFTER LIVING DONOR KIDNEY TRANSPLANTATION | Vassilios Papalois | ![]() |
![]() |
|||
507-P | MEASUREMENT OF THE IMMUNOSUPPRESSANT POSSESSION RATIO BY CLINICAL PHARMACISTS CAPTURES A NON-ADHERENCE ASSOCIATED WITH ANTIBODY-MEDIATED REJECTION | Jérémy Chambord | ![]() |
![]() |
|||
508-P | KNOWLEDGE EXCHANGE PROGRAM TO FACILITATE THE CREATION OF ORGAN DONATION UNITS IN SAUDI ARABIA | Brian Alvarez | ![]() |
![]() |
|||
509-P | POST-TRANSPLANT DIABETES MELLITUS IN KIDNEY TRANSPLANT PATIENTS ONE CENTRE PILOT, PROSPECTIVE STUDY. | Alicja Debska-Slizien | ![]() |
![]() |
|||
510-P | PREVALENCE AND RISK FACTORS FOR ARTERIAL HYPERTENSION IN LIVER TRANSPLANT RECIPIENTS | Nicoline Stender Arentoft | ![]() |
![]() |
|||
511-P | KIDNEY TRANSPLANT IN HIGHLY SENSITIZED PATIENT: IMLIFIDASE DESENSITIZATION, C1Q-BINDING DELISTING AND TIMELY TREATMENT OF ANTIBODY-MEDIATED REJECTION | Lucrezia Furian | ![]() |
![]() |
|||
515-P | THE EFFECT OF STEM CELL-DERIVED EXTRACELLULAR VESICLES ON ISCHEMIA REPERFUSION INJURY IN SOLID ORGAN TRANSPLANTATION: A SYSTEMATIC REVIEW | Nicholas Gilbo | ![]() |
![]() |
|||
517-P | EXTRACELLULAR MATRIX - KEY COMPONENT IN THE PRODUCTION OF FUNCTIONAL AND PHYSIOLOGICALLY STABLE ARTIFICIAL PANCREATIC ISLETS USING THE INKJET METHOD | Michal Wszola | ![]() |
![]() |
|||
518-P | HEALTHCARE WORKERS AND ADMINISTRATIVE STAFF PERCEPTION OF ORGAN DONATION IN TWO HOSPITALS | Andrea Garcia Lopez | ![]() |
![]() |
|||
519-P | THE MANY FACES OF HUMAN HERPES VIRUS 8 (HHV 8) DISEASE: CASE REPORT OF A PAEDIATRIC LIVER TRANSPLANT RECIPIENT | Marisa Beretta | ![]() |
![]() |
|||
520-P | COMPARATIVE ANALYSIS OF INCOMPATIBLE ABO VS INCOMPATIBLE HLA LIVING DONOR KIDNEY TRANSPLANTATION | Sara Domenica Erraez Guerrero | ![]() |
![]() |
|||
521-P | GENE EXPRESSION ANALYSIS AND HISTOLOGICAL DIAGNOSIS OF TRANSPLANT BIOPSIES TAKEN AT THE TIME OF DONOR-SPECIFIC ANTIBODY DETECTION. | Jack Beadle | ![]() |
![]() |
|||
522-P | SOCIAL SUPPORT AND EDUCATION REINFORCEMENT MODIFIABLE FACTORS FOR NON-COMPLIANCE IN RENAL TRANSPLANT RECIPIENTS. RESULTS OF A CROSS-SECTIONAL STUDY. | Andrea Garcia Lopez | ![]() |
![]() |
|||
523-P | A POLICY OF VERY SHORT PRESERVATION TIME IMPROVES THE RESULTS OF SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION FROM EXTENDED CRITERIA DONORS | Renaud Snanoudj | ![]() |
![]() |
|||
525-P | THROMBOTIC MICROANGIOPATHY AFTER ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: ASSESSMENT OF ANTI-A ANTIBODIES BY LUMINEX SINGLE ANTIGEN ASSAY. | Dominique Bertrand | ![]() |
![]() |
|||
526-P | EARLY CMV REACTIVATION IN RENAL RECIPIENTS IS ASSOCIATED WITH PRE-TRANSPLANT HIGH EXPRESSION OF BCMA TRANSCRIPTS, PLASMABLAST & CLASS-SWITCHED B CELL | Manuel Muro | ![]() |
![]() |
|||
527-P | CURRENT INSIGHTS INTO THE METABOLOME DURING HYPOTHERMIC KIDNEY PERFUSION. | Laurence Verstraeten | ![]() |
![]() |
|||
529-P | PERCEPTIONS, EMOTIONS AND SOCIAL REPRESENTATIONS RELATED TO ORGAN DONATION IN HEALTHCARE WORKERS: A QUALITATIVE RESEARCH STUDY AFTER THE COVID-19 | Margherita Gentile | ![]() |
![]() |
|||
530-P | CLINICAL UTILITY OF GENETIC TESTING IN A KIDNEY TRANSPLANT CLINIC | Aina Quilis | ![]() |
![]() |
|||
531-P | VALIDITY OF CT DEFINED BODY COMPOSITION AS A PROGNOSTIC FACTOR FOR LONG TERM FUNCTIONAL OUTCOME IN KIDNEY TRANSPLANTATION RECIPIENTS. | Tim Swaab | ![]() |
![]() |
|||
532-P | YOUR DEATH, MY LIFE - A FOCUS GROUP STUDY REGARDING THE ATTITUDES OF THE GREEK POPULATION TOWARDS ORGAN DONATION AFTER CIRCULATORY DEATH | Christina Papachristou | ![]() |
![]() |
|||
534-P | RACE-FREE VERSUS RACE-DEPENDENT ESTIMATED GLOMERULAR FILTRATION RATE AMONG KIDNEY-TRANSPLANTED PATIENTS ONE YEAR AFTER TRANSPLANTATION | Ingrid Charlotte Kongerud | ![]() |
![]() |
|||
535-P | RECIPIENT WARM ISCHEMIA TIME AND ITS IMPACT ON GRAFT FUNCTION AND HISTOLOGY AT 3 MONTHS | Yosu Luque | ![]() |
![]() |
|||
536-P | IMMEDIATE VERSUS DELAYED ABDOMINAL WALL CLOSURE AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION USING A GORE-TEX PATCH: A SINGLE CENTER EXPERIENCE | Valeria Wagner | ![]() |
![]() |
|||
537-P | ASYMPTOMATIC GRAFT INFECTION | Pooja Budhiraja | ![]() |
![]() |
|||
538-P | LETERMOVIR AS A RESCUE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH VALGANCICLOVIR/GANCICLOVIR REFRACTORY/RESISTANT CMV DISEASE | Linde Gao | ![]() |
![]() |
|||
539-P | ORTHOTOPIC ROBOT-ASSISTED KIDNEY TRANSPLANTATION: A NOVEL TECHNIQUE AND CASE SERIES | Begońa Etcheverry Giadrosich | ![]() |
![]() |
|||
540-P | PROGNOSTIC VALUE OF A POSITIVE CROSSMATCH BEFORE DESENSITIZATION IN A COHORT OF HIGHLY-SENSITIZED PATIENTS | Johan Noble | ![]() |
![]() |
|||
542-P | EDUCATIONAL INTERVENTION AS AN APPROACH TO SUPPORT COUNTRIES IN EUROPEAN REGION TOWARDS ACHIEVING SELF-SUFFICIENCY IN TRANSPLANTATION | Chloe Balleste | ![]() |
![]() |
|||
544-P | VISIONEM AN AI PLATFORM FOR ORGAN ASSESSMENT | Concepción Gómez-Gavara | ![]() |
![]() |
|||
545-P | ENHANCED VIABILITY AND FUNCTION DURING PROLONGED CARDIAC GRAFT PRESERVATION USING THE VP.S ENCORE OXYGENATED MACHINE PERFUSION DEVICE | Kristina Andrijauskaite | ![]() |
![]() |
|||
546-P | SEARCHING NEW DONATION SCENARIOS: POTENCIAL RECEPTORS ON THE OTHER SIDE OF THE MIRROR | Ramón Mula Martínez | ![]() |
![]() |
|||
547-P | PERSISTENT HYPERPARATHYROIDISM AFTER PREEMPTIVE KIDNEY TRANSPLANTATION | Manabu Okada | ![]() |
![]() |
|||
548-P | A RANDOMISED CONTROLLED TRIAL TO COMPARE STANDARD AND TORQUE TENO VIRUS GUIDED IMMUNOSUPPRESSION AFTER KIDNEY TRANSPLANTATION - TTVGUIDEIT PROTOCOL | Frederik Haupenthal | ![]() |
![]() |
|||
549-P | Mycophenolate mofetil severely hampers protective antibody responses to a broad range of vaccinations in kidney transplant recipients: results from a randomized controlled study. | Zainab Al Fatly | ![]() |
![]() |
|||
550-P | INCREASING ACCESS TO LIVING DONOR TRANSPLANTS BY OVERCOMING BARRIERS TO RECIPIENTS IDENTIFYING A LIVING DONOR | Bruce Gelb | ![]() |
![]() |
|||
551-P | PRE-TREATMENT OF DONOR TISSUE IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: A SYSTEMATIC REVIEW | David Tran | ![]() |
![]() |
|||
552-P | ASSOCIATION BETWEEN INTRAOPERATIVE FLUID MANAGEMENT AND POSTOPERATIVE OUTCOMES IN LIVING KIDNEY DONORS | Chisong Chung | ![]() |
![]() |
|||
553-P | RNA-SEQUENCING REVEALS A CONSERVED MECHANISM OF ACUTE REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION ACROSS PATIENTS AND ANATOMICAL LOCATION | David Tran | ![]() |
![]() |
|||
554-P | STREAMLINING DONATION TRANSPLANTATION COMMUNICATION VIA HIPAA-COMPLIANT APP | John Piano | ![]() |
![]() |
|||
555-P | STREAMLINING TRANSPLANTATION VIA A COMPREHENSIVE AND SECURE DIGITAL TRANSPLANT MANAGEMENT PLATFORM | John Piano | ![]() |
![]() |
|||
557-P | TECHNICAL FEASIBILITY OF WHOLE-EYE VASCULAR COMPOSITE ALLOTRANSPLANTATION: A SYSTEMATIC REVIEW | David Tran | ![]() |
![]() |
|||
558-P | SAFETY AND UTILITY OF ADJUVANT AND CONCOMITANT PANNICULECTOMY IN RENAL TRANSPLANT CANDIDATES | David Tran | ![]() |
![]() |
|||
559-P | THE ROLE OF T-LYMPHOCYTES IN ACUTE REJECTION FOLLOWING VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | ![]() |
![]() |
|||
560-P | CHARACTERIZING B-LYMPHOCYTE MEDIATED REJECTION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | ![]() |
![]() |
|||
561-P | MINIMALLY AND NON-INVASIVE REJECTION MONITORING MODALITIES IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION | David Tran | ![]() |
![]() |
|||
565-P | OUTCOMES OF KIDNEY TRANSPLANTATIONS FROM DECEASED DONORS WITH ANURIC/OLIGURIC ACUTE KIDNEY INJURY | Cheol Woong Jung | ![]() |
![]() |
|||
566-P | THE PREDICTIVE VALUE OF AORTOILIAC CALCIFICATION OF DECEASED DONORS FOR CHRONICITY SCORE OF BIOPSIES AND GRAFT OUTCOMES IN KIDNEY TRANSPLANTATION | Cheol Woong Jung | ![]() |
![]() |
|||
567-P | SUCCESSFUL LUNG TRANSPLANTATION FROM HEPATITIS C VIREMIC DONORS IN CRITICALLY ILL RECIPIENTS | Jasleen Kukreja | ![]() |
![]() |
|||
569-P | UROLOGIC COMPLICATIONS IN OUR ORGAN TRANSPLANT UNIT AFFECTING RECIPIENTS FROM BRAID DEAD DONORS DURING THE LAST DECADE. | NIKOLAOS DIMITROKALLIS | ![]() |
![]() |
|||
570-P | BUBBLE AND INTERMITTENT SURFACE OXYGENATION ARE AN EFFECTIVE ALTERNATIVE FOR MEMBRANE-OXYGENATED HMP-KIDNEYS TO MAINTAIN AEROBIC METABOLISM. | Tom Darius | ![]() |
![]() |
|||
571-P | COMPARATIVE STUDY OF PATHOGENS AFFECTING OUR KIDNEY TRANSPLANT UNIT FOLLOWING CHANGE IN ANTIBIOTIC PROPHYLAXIS PROTOCOL DURING THE PERIOD 2010-2022. | Nikolaos Dimitrokallis | ![]() |
![]() |
|||
572-P | THROMBOTIC MICROANGIOPATHY AND EARLY HUMORAL REJECTION AFTER ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: A FRENCH MULTICENTER CASE-CONTROL STUDY. | BERTRAND Dominique | ![]() |
![]() |
|||
574-P | SOTROVIMAB AS PRE-EXPOSITION PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS: NEUTRALIZATION OF OMICRON BA.1 AND BA.2 VARIANTS | Roman Reindl-Schwaighofer | ![]() |
![]() |
|||
577-P | SPLIT RENAL FUNCTION, RENAL VASCULAR VARIATIONS AND DONOR PREFERENCES: CHALLENGE AND CROSSROADS TOWARDS RIGHT KIDNEY CHOICE | Zaklina Sterjova | ![]() |
![]() |
|||
578-P | NOVEL PROGNOSTIC MARKERS FOR LIVER CIRRHOSIS IN PATIENTS ON THE ROMANIAN WAITING LIST FOR LIVER TRANSPLANT | Speranta Iacob | ![]() |
![]() |
|||
580-P | RECOMBINANT SARS-COV-2-ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITHOUT NEUTRALIZING ANTIBODIES FOLLOWING FULL VACCINATION (RESCUE-TX) | Andreas Heinzel | ![]() |
![]() |
|||
582-P | MORTALITY OF THE CIRRHOTIC PATIENTS ON THE LIVER TRANSPLANT WAITING LIST DURING THE COVID-19 PANDEMIC | Girleanu Irina | ![]() |
![]() |
|||
583-P | PRETRANSPLANT EVALUATION OF LIVING KIDNEY DONORS AND RECIPIENTS: FROM THEPERSPECTIVE OF THE TRANSPLANT COORDINATORS. | Xanthi Sarantzi | ![]() |
![]() |
|||
585-P | HLA MOLECULAR MISMATCH AND HLA-SPECIFIC MEMORY B CELLS BEFORE AND AFTER KIDNEY TRANSPLANTATION IN FEMALE CANDIDATES SENSITIZED BY PREGNANCIES | Sara Sanz-Ureńa | ![]() |
![]() |
|||
586-P | COMPARISON OF THE IMPACT OF NORMOTHERMIC AND HYPOTHERMIC PRESERVATION METHODS ON KIDNEY LIPIDOMIC PROFILE USING SPME CHEMICAL BIOPSY | Natalia Warmuzinska | ![]() |
![]() |
|||
587-P | MEDIA COVERAGE OF PATIENTS WAITING FOR A TRANSPLANT INFLUENCES HEALTHCARE WORKERS IN AN UNPREDICTABLE WAY, BUT NOT THE SOCIETY | Francisca Gonzalez Cohens | ![]() |
![]() |
|||
588-P | LUMINEX SINGLE ANTIGEN ASSAY ON 1:10 DILUTED SERUM PREDICTS THE DROP IN ANTI-HLA ANTIBODIES BEFORE DESENSITIZATION OR TREATMENT OF HUMORAL REJECTION | Dominique Bertrand | ![]() |
![]() |
|||
589-P | REENGINEERING, THE TOOL THAT CAN REVOLUTIONIZE ORGAN PROCUREMENT IN CHILE | Francisca Gonzalez Cohens | ![]() |
![]() |
|||
591-P | ORGAN DONATION A CROSS-SECTIONAL SURVEY AMONG MEDICAL STUDENTS IN ROMANIA | Girleanu Irina | ![]() |
![]() |
|||
592-P | PANCREATIC ISLET CONDITIONING FOR TRANSPLANTATION BY RNA INTERFERENCE | Jan Kriz | ![]() |
![]() |
|||
593-P | PREGNANCY INDUCED SENSITISATION AND HLA-ANTIBODY INCOMPATIBLE KIDNEY TRANSPLANTATION (HLA-AIT): NOT ALL IS BAD NEWS FOR LONG TERM GRAFT SURVIVAL. | Sunil Daga | ![]() |
![]() |
|||
594-P | ADULT KIDNEY TRANSPLANT RECIPIENTS AT RISK OF CMV INFECTION AND DISEASE: AN OBSERVATIONAL STUDY | Gerrit Burger | ![]() |
![]() |
|||
595-P | ASSOCIATION OF BODY COMPOSITION WITH PRESENCE OF SUBCLINICAL TARGET ORGAN DAMAGE IN KIDNEY TRANSPLANT RECIPIENTS. | Marilena Kylla | ![]() |
![]() |
|||
597-P | BENEFIT OF LIVING DONOR LIVER TRANSPLANTATION IN GRAFT SURVIVAL FOR EXTREMELY HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE = 35 | Sang Oh Yun | ![]() |
![]() |
|||
598-P | REDUCED FRAILTY AND IMPROVED FUNCTIONAL CAPACITY IN EXERCISING LIVER TRANSPLANT CANDIDATES | Ilias Marios Oikonomou | ![]() |
![]() |
|||
600-P | EXPERIENCE OF LIVER TRANSPLANTATION IN NATIONAL SCIENTIFIC CENTER FOR SURGERY NAMED AFTER A.N. SYZGANOV | Bolatbek Baimakhanov | ![]() |
![]() |
|||
601-P | REVISED CRITERIA FOR DIASTOLIC DYSFUNCTION OF CIRRHOTIC CARDIOMYOPATHY AND MAJOR ADVERSE CARDIAC EVENTS AFTER LIVER TRANSPLANT. | Jeayoun Kim | ![]() |
![]() |
|||
602-P | NEW NON-INVASIVE MARKERS OF PORTAL HYPERFLOW AND ITS ROLE IN CIRRHOSIS AND POST-LIVER TRANSPLANT OUTCOME | Luca Del prete | ![]() |
![]() |
|||
604-P | SARS-COV-2 SUBGENOMIC RNA IN KIDNEY TRANSPLANT RECIPIENTS. UTILITY IN PROGNOSIS OF PATIENTS WHO HAVE RECEIVED REMDESIVIR. | Judit Cacho | ![]() |
![]() |
|||
605-P | LIVER AUTO-TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS TO DEFINE INDICATIONS AND DETERMINE SURVIVAL | Eleonora Nieddu | ![]() |
![]() |
|||
606-P | NUCLEIC ACID TESTING TO FACILIATE KIDNEY TRANSPLANTATION FROM INCREASED-INFECTIOUS RISK DECEASED DONORS: CLINICAL OUTCOMES AND VIRAL TRANSMISSION RISK | Laura Kenny | ![]() |
![]() |
|||
607-P | COMPARING OUTCOMES OF FIRST AND SECOND DECEASED DONOR KIDNEY TRANSPLANTATION: A RETROSPECTIVE STUDY | Sunghyo An | ![]() |
![]() |
|||
608-P | ASSOCIATION BETWEEN BODY COMPOSITION AND ANKLE-BRACHIAL INDEX IN KIDNEY TRANSPLANT RECIPIENTS. | Maria Perdikouli | ![]() |
![]() |
|||
609-P | THE EARLY ALLOGRAFT FAILURE SIMPLIFIED ESTIMATION SCORE OUTPERFORMS CLASSIC OLTHOFF EAD IN PREDICTING 90-DAY GRAFT LOSS IN DCD LIVER TRANSPLANTATION | Femke de Goeij | ![]() |
![]() |
|||
610-P | OUTCOME OF PATIENTS WITH C3 GLOMERULONEPHRITIS AFTER LIVING DONOR KIDNEY TRANSPLANTATION | Christina Melexopoulou | ![]() |
![]() |
|||
611-P | EPRO DIARY LIVER: A NEW WAY TO PROMOTE PATIENT COMPLIANCE AND MORE | Luisa Pasulo | ![]() |
![]() |
|||
612-P | Immunosuppression non-adherence in kidney transplant patients: a comparison between short-term (1 year post-transplant), long-term (3 years post-transplant) and patients with a failing graft (GFR 20mL/min) | Rosie Heape | ![]() |
![]() |
|||
613-P | ASSOCIATION BETWEEN PHENOTYPES OF BLOOD PRESSURE CONTROL AND BODY COMPOSITION IN KIDNEY TRANSPLANT RECIPIENTS. | Theodora Penna | ![]() |
![]() |
|||
615-P | BK VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS UNDERGOING REGULAR SCREENING | Daniel Bräuner Rasmussen | ![]() |
![]() |
|||
616-P | DISEASE COURSE, MANAGEMENT AND OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS WITH SARS COV2 INFECTION DURING THE OMICRON WAVE: A SINGLE-CENTER EXPERIENCE. | Kalliopi Vallianou | ![]() |
![]() |
|||
618-P | EARLY OUTCOMES OF LIVER TRANSPLANTS AFTER NORMOTHERMIC MACHINE PERFUSION | Ioannis D. Kostakis | ![]() |
![]() |
|||
620-P | PHOSPHATIDYLETHANOL AS A MARKER FOR THE DIAGNOSIS OF ALCOHOL RELAPSE AFTER LIVER TRANSPLANTATION: SINGLE CENTRE EXPERIENCE | Svetlana Adamcova Selcanova | ![]() |
![]() |
|||
621-P | ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO PREDICT FUNCTIONAL OUTCOME OF THE ARTERIOVENOUS FISTULAE IN A PATIENTS WITH END-STAGE RENAL FAILURE | Mahmoud Mohamed Tolba | ![]() |
![]() |
|||
623-P | LIVER TRANSPLANTATION FOR ECSTASY INDUCED FULMINANT HEPATIC FAILURE: THE NEED FOR GUIDELINES. | Stavros Neiros | ![]() |
![]() |
|||
624-P | ASSOCIATION OF VESSEL-SPECIFIC CORONARY ARTERY STENOSIS WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RENAL TRANSPLANT CANDIDATE COHORT | Bing Jie Chow | ![]() |
![]() |
|||
625-P | NORMOTHERMIC REGIONAL PERFUSION REDUCES APOPTOSIS MARKERS IN CONTROLLED DONATION AFTER DETERMINATION OF DEATH | Gabriel Moreno-Gonzalez | ![]() |
![]() |
|||
626-P | PEDIATRIC LUNG TRANSPLANTATION ON EXTRACORPOREAL MEMBRANE OXYGENATION SUPPORT WITH PERIPHERAL CANNULATION: A SINGLE CENTER EXPERIENCE | Arianna Trizzino | ![]() |
![]() |
|||
627-P | LONG TERM EFFECTS OF COMPOSITE WARM AND COLD ISCHAEMIC TIME IN DECEASED DONOR KIDNEY TRANSPLANTATION | Muhammad Khurram | ![]() |
![]() |
|||
628-P | 30 YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: AN APPRECIATION OF ITS SURVIVAL BENEFIT OVER KIDNEY TRANSPLANTATION ALONE | Elisabet Van Loon | ![]() |
![]() |
|||
630-P | LEFT LOBE LIVER VOLUME CALCULATION USING REALITY CAPTURE HARDWARE VIA LIGHT DETECTION AND RANGING (LIDAR) 3D TECHNOLOGY | Konstantina Eleni Karakasi | ![]() |
![]() |
|||
631-P | TOWARDS THE DEVELOPMENT OF A REGIONAL PEDIATRIC DCD NETWORK MODEL: A PREPARATORY SURVEY | Maria Adele Figini | ![]() |
![]() |
|||
632-P | EFFECT ON HUMORAL SENSITIZATION OF DUAL TARGETING APPROACH WITH ANTI-CD38 MAB AND COSTIMULATION BLOCKADE IN HIGHLY SENSITIZED PATIENTS (COMBAT STUDY) | Delphine Kervella | ![]() |
![]() |
|||
633-P | DUAL INDUCTION WITH ANTI-THYMOCYTE GLOBULIN AND RITUXIMAB IN SENSITIZED KIDNEY TRANSPLANT PATIENTS. | Joon Heon Jeong | ![]() |
![]() |
|||
634-P | DE NOVO UPPER TRACT UROTHELIAL CARCINOMA AFTER RENAL TRANSPLANTATION | Jian Zhang | ![]() |
![]() |
|||
636-P | A NOVEL APPROACH TO ADDRESS MASS MEDIA CAMPAIGNS FOR ORGAN DONATION PROMOTION. THE REGIONAL EXPERIENCE OF A 5-MILION INHABITANTS AREA OF ITALY. | Giuseppe Feltrin | ![]() |
![]() |
|||
638-P | VOLUMETRIC ASSESSMENT OF HEPATIC GRAFTS USING LIGHT DETECTION AND RANGING (LIDAR )TECHNOLOGY | Konstantina Eleni Karakasi | ![]() |
![]() |
|||
639-P | SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION IN OLDER RECIPIENTS | Pooja Budhiraja | ![]() |
![]() |
|||
641-P | POST-TRANSPLANT DONOR SPECIFIC ANTIBODIES DYNAMICS CAN BE PREDICTED USING C3D ASSAY IN ASSESSMENT FOR HLA-INCOMPATIBLE KIDNEY TRANSPLANTATION | Sunil Daga | ![]() |
![]() |
|||
642-P | LATE NON-CATHETER-RELATED VENOUS THROMBOTIC EVENTS IN LUNG TRANSPLANT RECIPIENTS | Ivan Barone | ![]() |
![]() |
|||
643-P | DONATION AFTER CIRCULATORY DEATH IN INTESTINAL TRANSPLANTATION: THE PATH TO PROVE ITS VALIDITY IN BOTH EXPERIMENTAL AND CLINICAL MODELS | Javier Serradilla | ![]() |
![]() |
|||
644-P | TRANSPLANT RENAL ARTERY STENOSIS SURGICAL INTERVENTION: TIME IS GFR | Gozde Gultekin | ![]() |
![]() |
|||
645-P | THE IMPACT OF LIVE KIDNEY DONATION IN A KIDNEY EXCHANGE PROGRAMME ON THE HEALTH-RELATED QUALITY OF LIFE OF THE DONOR. | Stijn van de Laar | ![]() |
![]() |
|||
646-P | LIVING DONOR NEPHRECTOMY: COMPARISON OF LEARNING CURVES AND SURGICAL OUTCOMES OF ROBOTIC VS LAPAROSCOPIC TECHNIQUE FROM TWO EUROPEAN CENTERS | Leonardo Centonze | ![]() |
![]() |
|||
647-P | TRENDS AND COST OF HEART TRANSPLANTATION AND VENTRICULAR ASSIST DEVICES IN GREECE-A LOW ORGAN DONATION ENVIRONMENT. | Angeliki Gkouziouta | ![]() |
![]() |
|||
648-P | LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: DIFFERENCES IN PRE-TRANSPLANT RADIOLOGY VERSUS EXPLANT PATHOLOGY REPORTS AND IMPACT ON SURVIVAL | Ahmed Sherif | ![]() |
![]() |
|||
650-P | REVIEWING CARDIAC STRESS TESTING AS PART OF KIDNEY TRANSPLANTATION WORK-UP | Ashveer Randhay | ![]() |
![]() |
|||
651-P | Post-Transplant Lymphoproliferative Disorder: A Focus On Outcomes in Living-Donor and Extended-Criteria Kidney Recipients | Mehmet Ergisi | ![]() |
![]() |
|||
652-P | Evaluation of a Bead-Based non-HLA Antibody Detection Assay in Male Blood Donors Demonstrates Values up to 10x Cut-Off | Amogh Agrawal | ![]() |
![]() |
|||
653-P | PREDICTION OF GRAFT SURVIVAL PRIOR TO ACCEPTING AN OFFER FOR DECEASED DONOR KIDNEY TRANSPLANT: AN ARTIFICIAL INTELLIGENCE APPROACH | Hatem Ali | ![]() |
![]() |
|||
654-P | AVAILABILITY OF PRE-DONATION CLINICAL DATA AND OUTCOMES OF KIDNEY TRANSPLANT ALLOGRAFTS FROM DECEASED DIABETIC DONORS. | Anna Buxeda | ![]() |
![]() |
|||
655-P | EVALUATION OF KIDNEY DONOR RISK INDEX / KIDNEY DONOR PROFILE INDEX AS PREDICTOR TOOLS OF DECEASED-DONOR KIDNEY TRANSPLANT OUTCOMES IN A GREEK COHORT | Maria Darema | ![]() |
![]() |
|||
657-P | THE FALL OF A MYTH: THE FIRST THREE CASES OF DONATION AFTER CIRCULATORY DEATH IN INTESTINAL TRANSPLANTATION | Javier Serradilla | ![]() |
![]() |
|||
658-P | PREFORMED DONOR-SPECIFIC ANTIBODIES IN DECEASED-DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER STUDY | Ioannis Michelakis | ![]() |
![]() |
|||
659-P | IMPLEMENTATION OF NEW M-HEALTH TOOL TO MONITOR IMMUNOSUPPRESSION ADHERENCE AND VITAL PARAMETERS IN KIDNEY TRANSPLANT PATIENTS | Valme Rodriguez | ![]() |
![]() |
|||
660-P | GENE EXPRESSION PROFILES OF PERITUBULAR CAPILLARITS IN CHRONIC ANTIBODY-MEDIATED REJECTION | Michael Eder | ![]() |
![]() |
|||
662-P | TRANSPLANTATION OF EXTENDED CRITERIA DECEASED DONOR KIDNEYS TO EXTENDED CRITERIA RECIPIENTS: A CHALLENGING COHORT | HAITHAM SOLIMAN | ![]() |
![]() |
|||
663-P | PREEMPTIVE KIDNEY TRANSPLANTATION: EXPANDING TO ALL KIND OF DONORS AND RECEPTOR | Javier Arias Alcalá | ![]() |
![]() |
|||
664-P | DECEASED ORGAN DONATION ACTIVITY, IN THE CRITICAL CARE UNIT OF A GREEK UNIVERSITY HOSPITAL, DURING 2022 | FRANTZESKA FRANTZESKAKI | ![]() |
![]() |
|||
665-P | LONG TERM OUTCOMES OF COMBINED LIVER KIDNEY TRANSPLANTATION | Conor Hennessy | ![]() |
![]() |
|||
666-P | ESTIMATING TIME TO LIVER TRANSPLANTATION USING PROGNOSIS SCORES IN PATIENTS WITH LARGE-DUCT PRIMARY SCLEROSING CHOLANGITIS | Speranta Iacob | ![]() |
![]() |
|||
668-P | EVALUATING THE BIDIRECTIONAL IMPACT OF KIDNEY TRANSPLANTATION AND HIV CONTROL | Fatima Ali | ![]() |
![]() |
|||
669-P | EPH RECEPTOR SIGNALLING AND CELL MIGRATION IN 3 D CELL CULTURES THROUGH EPHRIN MIMETIC PEPTIDES | Aiste Gulla | ![]() |
![]() |
|||
670-P | CHRONIC ALLOGRAFT NEPHROPATHY IS AGGRAVATED IN AGED DONORS BY THE EXACERBATION OF AGE-RELATED LOSS OF PROTECTIVE FACTORS | Elisenda Banon-Maneus | ![]() |
![]() |
|||
671-P | MI-EDON STUDY: THE ROLE OF RESPIRATORY PHYSIOTHERAPY AS TOOLS FOR THE OPTIMIZATION OF THE LUNG DONOR. | Alberto Sandiumenge | ![]() |
![]() |
|||
672-P | LAPAROSCOPIC LIVE DONOR NEPHRECTOMY AND VASCULAR ANATOMICAL VARIATIONS: A CHALLENGE FOR THE TRANSPLANT SURGEON. | Dionysios Prevezanos | ![]() |
![]() |
|||
673-P | READMISSIONS TO KIDNEY TRANSPLANTATION DEPARTMENT: INCIDENCE, CAUSES AND RISK FACTORS | tlili syrine | ![]() |
![]() |
|||
674-P | MEDIAN ARCUATE LIGAMENT COMPRESSION-AN ACHILLEAS KNEE FOR HEPATIC ARTERY FLOW DURING LIVER TRANSPLANTATION | Cristian Lupascu | ![]() |
![]() |
|||
675-P | PHOTOPROTECTION AND SKIN CANCER AWARENESS IN KIDNEY TRANSPLANT RECIPIENTS LIVING WITH HIV: A SINGLE-CENTRE CROSS-SECTIONAL STUDY | Fatima Ali | ![]() |
![]() |
|||
676-P | THE DEVELOPMENT OF REJECTION IS ASSOCIATED WITH A MORE AGGRESSIVE PATTERN OF POSTTRANSPLANT NEOPLASIA | Elena Cuadrado-Payán | ![]() |
![]() |
|||
677-P | BEST PRACTICES ALONG THE KIDNEY TRANSPLANTATION CLINICAL JOURNEY: A QUANTITATIVE SURVEY TOOL | Sara Machado | ![]() |
![]() |
|||
678-P | 3D BIOPRINTING OF A BIONIC PANCREAS WITH A VASCULAR SYSTEM RESULTS OF TRANSPLANTATION IN LARGE ANIMALS. | Michal Wszola | ![]() |
![]() |
|||
679-P | THE BURDEN OF SKIN DISEASE IN KIDNEY TRANSPLANT RECIPIENTS LIVING WITH HIV: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS | Fatima Ali | ![]() |
![]() |
|||
680-P | KIDNEY TRANSPLANTATION IN ALBANIA: A SINGLE CENTER EXPERIENCE | Elvana Rista | ![]() |
![]() |
|||
681-P | VALGANCICLOVIR PROPHYLAXIS IN HIGH-RISK TRANSPLANT RECIPIENTS: A DOUBLE-EDGED SWORD WITH IMPLICATIONS FOR NEUTROPENIA AND KIDNEY GRAFT SURVIVAL | Fabian Halleck | ![]() |
![]() |
|||
682-P | GLOBAL BURDEN OF CYTOMEGALOVIRUS RESISTANCE TO ANTIVIRALS IN FRANCE | Sophie Alain | ![]() |
![]() |
|||
684-P | INPATIENT REHABILITATION AFTER LIVER TRANSPLANTATION IN A DEDICATED REHABILITATION HOSPITAL IS FEASIBLE, SAFE, AND EFFECTIVE. | Lydia Christoforidi | ![]() |
![]() |
|||
685-P | OUTCOME OF KIDNEY TRANSPLANTATION IN PATIENTS WITH BALKAN ENDEMIC NEPHROPATHY | Stela Zivcic-Cosic | ![]() |
![]() |
|||
687-P | THE STRUCTURE OF THE SYSTEM OF TRANSPLANT COORDINATORS IN POLAND. | Teresa Danek | ![]() |
![]() |
|||
689-P | INTRAPATIENT VARIABILITY AND TESTS ABOVE LOWER TACROLIMUS TRESHOLD ARE ASSOCIATED WITH ACUTE REJECTION IN PANCREAS TRANSPLANTATION | Diana Rodríguez-Espinosa | ![]() |
![]() |
|||
690-P | THE IMPACT OF SURGICAL SITE INFECTIONS (SSI) ON OUTCOME AFTER DECEASED DONOR LIVER TRANSPLANT | Femke de Goeij | ![]() |
![]() |
|||
691-P | NONCODINGRNA-BASED BIOMARKERS IN AFP NORMAL HEPATOCELLULAR CARCINOMA: LNCRNA SNGH1 PLAYS AN IMPORTANT ROLE IN RECURRENCE AFTER LIVER TRANSPLANTATION | Secil Ak Aksoy | ![]() |
![]() |
|||
693-P | PERI-TRANSPLANT DESENSITIZATION WITH APHERESIS AND RITUXIMAB IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED DONOR-SPECIFIC ANTIBODIES AND A NEGATIVE CDC CROSSMATCH. A SINGLE EXPERIENCE CENTRE. | Cinthia Carolina Baldallo Moreno | ![]() |
![]() |
|||
694-P | LONGITUDINAL ANALYSIS OF ANTIBODIES IMMUNE RESPONSES IN KIDNEY TRANSPLANT RECIPIENTS AFTER SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | Ana Pinho | ![]() |
![]() |
|||
695-P | LAPAROSCOPIC LIVE DONOR NEPHRECTOMY AND SIMULTANEOUS LAPAROSCOPIC OPERATIONS.EVOLUTION OF MINIMAL INVASIVE LIVE DONOR NEPHRECTOMY. | Apostolos Angelis | ![]() |
![]() |
|||
696-P | IMPACT OF DELAYED GRAFT FUNCTION COMBINATION WITH OTHER COMPLICATIONS ON LATE POSTTRANSPLANT OUTCOMES. | Janis Jushinskis | ![]() |
![]() |
|||
697-P | AFTER A STEPWISE METHODOLOGY TO SHAPE A NATIONAL ALLOCATION SCORING SYSTEM FOR LIVER TRANSPLANTATION, WHICH IS THE BEST METRICS TO EVALUATE RESULTS? | Silvia Trapani | ![]() |
![]() |
|||
698-P | A SINGLE CELL TRANSCRIPTOMIC LANDSCAPE OF KIDNEY ENDOTHELIAL CELLS, FROM KIDNEY ORGANOIDS TO MATURE KIDNEY | Hector Tejeda Mora | ![]() |
![]() |
|||
700-P | ANTICOAGULANT AND ANTIPLATELET USE IN RENAL TRANSPLANTATION: IS PERIOPERATIVE BLOOD LOSS AND TRANSFUSION RATES A SIGNIFICANT CONCERN? | John Black | ![]() |
![]() |
|||
701-P | EVOLUTION OF MINIMAL INVASIVE LIVE DONOR NEPHRECTOMY:TECHNIQUES AND OUTCOMES FROM THE BUSIEST GREEK RENAL TRANSPLANT CENTER,IN LAIKO GENERAL HOSPITAL | Spyridon Vernadakis | ![]() |
![]() |
|||
702-P | WHEN MORE IS NOT BETTER BIG DATA AND MACHINE LEARNING IN ASSESSING THE RISK OF COVID-19 INFECTION IN SOT RECIPIENTS AND PATIENTS ON WAITING LIST | Dorota Kaminska | ![]() |
![]() |
|||
703-P | IMPACT OF HEPATIC VEIN RECONSTRUCTION TECHNIQUE ON VENOUS OUTFLOW OBSTRUCTION IN VENA-CAVA SPARING (PIGGYBACK) DECEASED DONOR LIVER TRANSPLANT | Gianna Fernandez | ![]() |
![]() |
|||
704-P | ROBOTIC SURGERY TO SOLVE URINARY TRACT COMPLICATIONS AFTER KIDNEY TRANSPLANTATION | Begońa Etcheverry Giadrosich | ![]() |
![]() |
|||
705-P | THE COMPASSIONATE MINDFUL RESILIENCE (CMR) PROGRAMME TO IMPROVE PSYCHOSOCIAL WELLBEING IN PEOPLE WITH KIDNEY DISEASE | Helen Noble | ![]() |
![]() |
|||
706-P | REAL-TIME ASSESSMENT OF PERFUSATE BIOMARKERS DURING EX SITU LIVER PERFUSION: A PILOT CLINICAL STUDY | Caterina Lonati | ![]() |
![]() |
|||
707-P | HEART TRANSPLANTATION IN RECIPIENTS OVER 60 YEARS-OLD: A SINGLE-CENTRE EXPERIENCE | Maria Simonenko | ![]() |
![]() |
|||
708-P | Sexual Dysfunction and Kidney Transplantation: A Scoping Review of Current Research | Clare Mckeaveney | ![]() |
![]() |
|||
709-P | STATE-OF-THE-ART LAPAROSCOPIC LIVE DONOR KIDNEY RETRIEVAL TWICE IN THE SAME PATIENT. A UNIQUE CASE IN THE WORLD LITERATURE. | Apostolos Angelis | ![]() |
![]() |
|||
710-P | TIMING OF PERITONEAL DIALYSIS CATHETER REMOVAL IN KIDNEY TRANSPLANT RECIPIENTS: A MULTICENTER PROPENSITY SCORE MATCHED COHORT STUDY | Piotr Domagala | ![]() |
![]() |
|||
711-P | SOCIAL TRENDS IN LIVING RENAL DONORS IN A SINGLE CENTER | tlili syrine | ![]() |
![]() |
|||
712-P | IMMUNOADSORPTION-BASED HLA DESENSITIZATION IN PATIENTS AWAITING DECEASED DONOR KIDNEY TRANSPLANTATION | Yosu LUQUE | ![]() |
![]() |
|||
713-P | NO ASSOCIATION BETWEEN ARTERIAL REPERFUSION TIME AND CLINICAL OUTCOMES FOR LIVER TRANSPLANTATION USING DONATION AFTER CIRCULATORY DEATH GRAFTS | Alessandro Parente | ![]() |
![]() |
|||
714-P | ADDED-VALUE OF RITUXIMAB AND PE ON TOP OF STANDARD INDUCTION THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED HIGH-TITER DSA | Yosu Luque | ![]() |
![]() |
|||
715-P | DECEASED DONOR LIVER TRANSPLANT (DDLT) WITH DUCT-TO-DUCT ANASTOMOSIS USING CONTINUOUS OR INTERRUPTED SUTURING, AND 5-0 OR 6-0 SUTURE SIZE | Gianna Fernandez | ![]() |
![]() |
|||
716-P | TACROLIMUS CONCENTRATION-TO-DOSE RATIO AND ITS ASSOCIATIONS WITH TACROLIMUS METABOLITES: PRELIMINARY ANALYSIS OF THE TIPS TRIAL | Thomas Jouve | ![]() |
![]() |
|||
717-P | PREDICTIVE OUTCOMES OF ACCEPTED AND DECLINED KIDNEY OFFERS: ARE WE DECLINING GOOD KIDNEYS ! | Mahmoud Mohamed Tolba | ![]() |
![]() |
|||
718-P | HEPATITIS B VIRUS REACTIVATION IN KIDNEY TRANSPLANT RECIPIENTS TREATED WITH BELATACEPT | Yosu Luque | ![]() |
![]() |
|||
726-P | IS THERE VALUE IN PROPHYLACTIC TREATMENT OF POST-TRANSPLANT RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS? A MULTICENTER RETROSPECTIVE STUDY. | Cyril GARROUSTE | ![]() |
![]() |
|||
727-P | PORTAL VEIN THROMBOSIS AND LIVER TRANSPLANTATION: OUR EXPERIENCE | Apostolos Angelis | ![]() |
![]() |
|||
728-P | PRE-TRANSPLANT MITOCHONDRIAL RESPIRATION IN HUMAN KIDNEY ALLOGRAFTS PREDICTS CLINICAL OUTCOME UPON TRANSPLANTATION | Andras T. Meszaros | ![]() |
![]() |
|||
729-P | EX-SITU SPLIT LIVER TRANSPLANTATION: A SAFE PARACHUTE PROCEDURE WHEN IN-SITU SPLITTING IS NOT POSSIBLE. | Zoe Larghi Laureiro | ![]() |
![]() |
|||
730-P | THE RING OF POWER -DIFFUSE SUB-EPICARDIAL LGE AS A NEW MARKER OF CARDIAC REJECTION IN HEART TRANSPLANT RECIPIENTS . | Angeliki Gkouziouta | ![]() |
![]() |
|||
731-P | ORAL SEMAGLUTIDE SAFETY IN KIDNEY TRANSPLANT RECIPIENTS WITH TYPE 2 DIABETES | Diana Rodríguez-Espinosa | ![]() |
![]() |
|||
732-P | EPIDEMIOLOGICAL AND CLINICAL CORRELATIONS BETWEEN ERECTILE DYSFUNCTION AND KIDNEY TRANSPLANT STATUS | Miron Adelina | ![]() |
![]() |
|||
734-P | INFLUENCE OF RENAL GRAFT FUNCTION IN PREGNANT WOMEN WHO UNDERWENT WITH KIDNEY TRANSPLANT | Cheng-Hsu Chen | ![]() |
![]() |
|||
735-P | ASSESSMENT OF EXTENDED CRITERIA DONOR LIVERS WITH INDOCYANINE GREEN DURING EX-VIVO MACHINE PERFUSION | Femke de Goeij | ![]() |
![]() |
|||
736-P | SHORT-TERM OUTCOME AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION WITH ALEMTUZUMAB VS. BASILIXIMAB INDUCTION; A SINGLE-CENTER RETROSPECTIVE STUDY | Tim Swaab | ![]() |
![]() |
|||
737-P | STABLE RECOVERY AFTER A MYOCARDITIS TREATED WITH CENTRAL ECMO AND IMPELLA: SHOULD WE DESIGN DIFFERENT ALLOCATION RULES FOR MYOCARDITIS? | Mario Passaro | ![]() |
![]() |
|||
738-P | KIDNEYS FROM UDCD WITH NRP SUPPORT VS KIDNEYS FROM BRAIN DEAD DONORS: A COMPARATIVE ANALYSIS OF TRANSPLANTATION OUTCOMES. | Ana Pinho | ![]() |
![]() |
|||
739-P | A RETROSPECTIVE OBSERVATIONAL STUDY ON THE DECLINING LIVER TRANSPLANT ASSESSMENT RATES AT EDINBURGH TRANSPLANT CENTRE | Ahmed Sherif | ![]() |
![]() |
|||
741-P | SHORT- AND LONGTERM OUTCOME IN LIVER TRANSPLANT RECIPIENTS WITH EARLY ALLOGRAFT DYSFUNCTION | Felix Oldhafer | ![]() |
![]() |
|||
742-P | TIXAGEVIMAB/CILGAVIMAB FOR PREVENTING SARS-COV-2 IN HEART TRANSPLANTED PATIENTS POOR VACCINE RESPONDERS: A HOPE OR YET ANOTHER GUY IN THE FIELD ? | Marco Masetti | ![]() |
![]() |
|||
743-P | CONTEMPORARY MANAGEMENT OF RENAL TRANSPLANT RECIPIENTS WITH DE NOVO URINARY STONES. A SINGLE INSTITUTION EXPERIENCE. | Maria Ramos-Cebrián | ![]() |
![]() |
|||
744-P | COVID-19 AND ACUTE PANCREATITIS IN KIDNEY TRANSPLANT RECIPIENTS | Danilo Radunovic | ![]() |
![]() |
|||
745-P | CLINICAL MANIFESTATIONS AND OUTCOMES OF CORONAVIRUS DISEASE-19 IN HEART TRANSPLANT RECIPIENTS. | Angeliki Gkouziouta | ![]() |
![]() |
|||
747-P | FIRST EXPERIENCE WITH COVID-19 VACCINATION IN HEART TRANSPLANT PATIENTS | Maria Simonenko | ![]() |
![]() |
|||
748-P | THE SERIOUS CONSEQUENCE OF DECREASE IMMUNOSSUPPRESSION AFTER COVID-19 IN A COHORT OF KIDNEY TRASPLANTATION | Javier Paul | ![]() |
![]() |
|||
749-P | ROLE OF CORONARY CALCIUM SCORE IN RULING OUT CORONARY ARTERY DISEASE AND IN WAITLIST PATIENTS SELECTION FOR LIVER TRANSPLANT CANDIDATES | Luigina Cocchiarella | ![]() |
![]() |
|||
752-P | A SINGLE CENTRE FIRST EXPERIENCE OF PAEDIATRIC HEART TRANSPLANTATION FROM ADULT DONORS | Maria Simonenko | ![]() |
![]() |
|||
754-P | A SINGLE-CENTRE EXPERIENCE OF COVID-19 MANAGEMENT IN HEART TRANSPLANT RECIPIENTS | Maria Simonenko | ![]() |
![]() |
|||
755-P | PRE-EXPOSURE PROPHYLAXIS WITH TIXAGEVIMAB/CILGAVIMAB IN A SLOVENIAN NATIONAL COHORT OF KIDNEY TRANSPLANT RECIPIENTS | pela Bortnar | ![]() |
![]() |
|||
756-P | ACUTE KIDNEY INJURY AFTER ALIROCUMAB APPLICATION IN A KIDNEY TRANSPLANT RECIPIENT WITH LUPUS NEPHRITIS A CASE REPORT | pela Bortnar | ![]() |
![]() |
|||
757-P | ROBOTIC VS LAPAROSCOPIC VS OPEN NEPHRECTOMY FOR LIVE KIDNEY DONATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROL TRIALS | Georgios Kourounis | ![]() |
![]() |
|||
758-P | NON HEART-BEATING DONOR PROGRAM FOR KIDNEY TRANSPLANTATION : FIVE YEAR RESULTS FROM A PORTUGUESE UNIT | Ines Aires | ![]() |
![]() |
|||
759-P | POST-TRANSPLANT DIABETES MELLITUS IN PEDIATRIC PATIENTS AFTER KIDNEY TRANSPLANTATION: INCIDENCE AND OUTCOMES. | Lina Maria Serna Higuita | ![]() |
![]() |
|||
760-P | CLINICAL IMPACT AND SAFETY OF ONE-YEAR DENOSUMAB THERAPY IN KIDNEY TRANSPLANT RECIPIENTS WITH OSTEOPOROSIS | Woo Yeong Park | ![]() |
![]() |
|||
762-P | SAFETY AND EFFICACY OF GLP1-RAS AND ISGLT-2- COMPARED WITH THE STANDARD OF CARE IN A COHORT OF LIVER TRANSPLANTED PATIENTS: A RETROSPECTIVE STUDY | Alessandra Mazzola | ![]() |
![]() |
|||
764-P | CLINICAL AND MOLECULAR SPECTRUM OF V-LESION | Anna Buxeda | ![]() |
![]() |
|||
765-P | DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS | Anna Buxeda | ![]() |
![]() |
|||
766-P | CHARACTERISTICS OF PROSPECTIVE AND EFFECTIVE LIVING DONORS FOR RENAL TRANSPLANTATION: A CROSS-SECTIONAL STUDY. | Andrea Garcia Lopez | ![]() |
![]() |
|||
767-P | THE CRITICAL PATHWAY FOR DECEASED DONATION: AN ANALYSIS IN THREE REGIONS OF COLOMBIA | Andrea Garcia Lopez | ![]() |
![]() |
17-20 September, Athens
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|